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Pancreatitis is characterized by inappropriate activation of digestive enzyme 
precursors, or zymogens, local and systemic inflammation, dysregulation of cellular 
calcium (Ca2+), and induction of the unfolded protein response (UPR). The UPR 
consists of three distinct pathways all of which are activated during pancreatitis.  
However, the molecular roles of each remain unclear. The protein kinase RNA 
(PKR)-like ER kinase (PERK) pathway reduces general protein translation by 
phosphorylating eIF2α, and is activated within minutes of initiating pancreatic 
damage. Microarray analysis carried out by our lab revealed robust upregulation of 
the PERK pathways members Activating Transcription Factor (ATF) 3 and 
stanniocalcin (STC) 2.  The roles of ATF3 and STC2 within the context of PERK 
signaling and pancreatitis are not well known.  Thus, the goal of this study was to 
define the roles of STC2 and ATF3 during pancreatitis.  Gene expression analysis 
revealed significant increases in STC2 during cerulein induced pancreatitis (CIP) 
and mice overexpressing STC2 (STC2Tg) exhibited decreased pancreatitis severity 
as evidenced by the maintenance of acinar cell differentiation markers, lower levels 
of serum amylase compared to wild type (WT) and a decreased necrosis to 
apoptosis ratio.  Conversely, ATF3 appears to function in an opposite fashion to 
STC2 during pancreatitis.  Chromatin immunoprecipitation (ChIP) of pancreatic 
tissue following CIP showed that ATF3 bound the Mist1 promoter, recruited Histone 
Deacteylasee (HDAC) 5 and repressed Mist1 expression, leading to loss of the 
acinar cell phenotype.  Human and mouse pancreatitis tissue samples reveal 
mutually exclusive expression of ATF3 and MIST1, illustrating clinical relevance for 
 iv 
 
ATF3.  Mice lacking Atf3 (Atf3-/-) exhibited a similar phenotype to STC2Tg mice, with 
increased maintenance of cellular junctions and cell polarity.  These findings suggest 
that these mediators of the PERK pathway lead to opposing outcomes, and that this 
pathway plays a dual role of both protection and injury during pancreatitis. 
Keywords 
Pancreatitis, unfolded protein response, PERK pathway, STC2, ATF3, transcription, 
acinar cell differentiation 
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Chapter 1  
1 « Historical Review» 
1.1 « Pancreatic Structure and Function »  
The pancreas is a dually functioning organ that serves to aid in the 
exocrine process of food digestion and the endocrine process of blood 
glucose homeostasis. To efficiently perform these two functions, the 
pancreas is composed of two discrete tissue types.    
1.1.1 « The Endocrine Pancreas »  
The endocrine pancreas represents approximately 2% of total pancreatic 
tissue.  The functional unit of the endocrine pancreas is the islet of 
Langerhans, which is composed of multiple cell types with varying 
functions.  Pancreatic β-cells make up the bulk of the islet, and function to 
produce and secret insulin to combat elevated blood glucose levels.  
Pancreatic α-cells envelop the islet, and produce and release glucagon to 
elevate blood glucose levels.  Pancreatic δ-cells, pancreatic polypeptide 
cells (PP-cells) and ε-cells produce somatostatin, pancreatic polypeptide 
and ghrelin, respectively.  Each of these three cell types makes up a small 
portion of the pancreatic islet.   
  
2 
1.1.2 « The Exocrine Pancreas »  
The exocrine pancreas is a compound acinar gland (Langerhans, 1869) 
that comprises 98% of total pancreatic tissue and produces enzymes 
required for digestion.  The functional unit of the exocrine pancreas is the 
acinus, composed of pancreatic acinar cells, centroacinar cells and duct 
cells. Pancreatic acinar cells are organized into discrete functional units 
called acini.  Multiple acini are grouped together to form a pancreatic 
lobule.  Within each acinus, the acinar cells are arranged with their apical 
ends adjacent to a central lumen that associates the cells with a 
pancreatic duct (Takahashi, 1984).  This organization allows for co-
ordinated secretion of enzymes from the cells directly into the pancreatic 
ductal network. Pancreatic duct cells are important not only because they 
form the structure of the pancreatic ductal network that delivers digestive 
enzymes to the gut, but also because they secrete bicarbonate.  
Bicarbonate is essential to the digestive process since it helps to 
neutralize the acid that moves from the stomach to the intestines during 
digestion.  Centroacinar cells reside between the acinar cells and duct 
cells, and while their role is not fully understood but it is thought that they 
may contribute to electrolyte secretion as well as growth and homeostasis 
of proximal duct structures.   
The duct network of the pancreas starts with the short, intercalated ducts 
associated with individual acini and collect secreted digestive enzymes.  
Intercalated ducts drain into intralobular ducts, which collect secretions 
  
3 
from acini situated in the same lobule.  Intralobular ducts merge with the 
larger, interlobular ducts that collect acinar secretions from multiple 
lobules and deliver them to the main pancreatic duct that runs the entire 
length of the pancreas. The main pancreatic duct merges with the bile 
duct prior to emptying into the duodenum (Figure 1.1).   
1.1.2.1 « Pancreatic Acinar Cells»  
Pancreatic acinar cells are polarized cells that produce and secrete 
digestive enzymes in response to hormonal stimulation.  These protein-
producing factories synthesize both mature digestive enzymes (amylase, 
lipase, elastase) and inactive digestive enzyme precursors, termed 
zymogens. Within the acinar cell, zymogens and digestive enzymes are 
restricted to vesicles called zymogen granules.  Containment of these 
proteins within zymogen granules prohibits activation of the enzymes and 
their exposure to the cell itself, limiting cellular digestion.  Mature digestive 
enzymes do not require further processing to become active, but become 
active only in the intestines.  Zymogens produced by pancreatic acinar 
cells include trypsinogen, chymotrypsinogen and procarboxypeptidase.  
After delivery to the small intestine, trypsinogen is cleaved to active trypsin 
by enteropeptidase in the intestinal mucosa.  Trypsin subsequently 











Figure 1.1.  Anatomy of the Exocrine Pancreas.  (A) Branching architecture of 
the exocrine pancreas.  Individual acini are grouped into grape-like lobules.  
Ducts emerging from singular acini. are intercalated ducts that then merge into 
intralobular ducts that further drain into interlobular ducts.  (B) Duct cells and 
centroacinar cells penetrate acini to facilitate digestive enzyme delivery to the 
small intestine.  Acini are composed of individual acinar cells that are organized 
with their apical ends toward the centre.  Nuclei are basally localized and 




























The organization of the pancreatic acinar cell is such that digestive 
enzymes are released from the apical aspect of the cells under normal 
conditions.  This allows for directed exocytosis into pancreatic ducts 
prohibiting indiscriminant enzyme release from other cell surfaces that can 
result in tissue damage and inflammation. To this end, pancreatic acinar 
cells are polarized, in that the cell nucleus is localized to the basal aspect 
of the cell (Ekholm, 1962), surrounded by the endoplasmic reticulum and 
the Golgi (reviewed in (Motta et al., 1997)).  A hallmark of the apical 
aspect of acinar cells is the accumulation of zymogen granules 
(McCuskey and Chapman, 1969).  Additionally, pancreatic acinar cells are 
associated via tight junctions near their apical ends (Friend and Gilula, 
1972; Galli et al., 1976), resulting in the formation of a fluid impermeable 
barrier around the acinar lumen.  This barrier functions to contain secreted 
digestive enzymes in the acinar lumen. Tight junctions also form a 
functional barrier, maintaining cell polarity by restricting diffusion of apical 
specific membrane proteins.  
The partitioning-defective (PAR)-atypical protein kinase C (aPKC) 
complex is required for establishment of cell polarity in the epithelial cell 
types of many species.  Most work defining the PAR-aPKC complex has 
been carried out in Saccharomyces cerevisiae and Drosophila 
melanogaster; however, mammalian homologs of PAR-aPKC proteins 
have been identified.  In mammals, PAR-6 interacts with aPKC and agouti 
  
7 
signaling peptide (ASIP)/PAR-3, and this complex colocalizes with Zona 
occludens-1 (ZO-1), a component of tight junctions (Izumi et al., 1998). 
PAR-6 further interacts with cell division control protein 42 (Cdc42) (Qiu et 
al., 2000), which establishes cell polarity by regulating polarized transport 
of secretory vesicles (Adamo et al., 2001) that is important for regulated 
exocytosis in pancreatic acinar cells. aPKC is required for establishment 
of apical-basal polarity and assembly of tight junctions, since lack of aPKC 
expression results in mis-localization of PAR-6, ASIP and ZO-1, resulting 
in loss of polarity and tight junction barrier function (Suzuki et al., 2001). In 
mammals, PKCζ is an atypical PKC and has been implicated in cell 
polarity through interactions with partitioning (PAR) proteins 3 and 6, 
which are involved in asymmetric cell division.  
1.1.2.2 « Regulated Exocytosis»  
The process by which digestive enzymes are secreted from acinar cells is 
called regulated exocytosis.  Regulated exocytosis in acinar cells is a 
tightly controlled process that is initiated by hormonal or neuronal stimuli.  
When chyme enters the duodenum, cells of the intestinal epithelium 
release secretagogues, one of which is cholecystokinin (CCK), a hormonal 
regulator of pancreatic acinar cell secretion.  Pancreatic acinar cells, and 
to a lesser extent, neurons of the central nervous system possess CCK-A 
receptors, which are G-protein coupled receptors (GPCRs) from the Gq 
family.  GPCRs interact with the trimeric G protein complex, which 
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includes α, β and γ subunits. Binding of CCK to the CCK-A receptor leads 
to dissociation of the α-subunit from the G-protein complex, and 
subsequent activation of phospholipase C-β (PLC-β), and cleavage of 
phosphatidylinositol 4,5-bisphosphate into inositol triphosphate (IP3) and 
diacylglycerol (DAG; (Matozaki and Williams, 1989)).  IP3 binds to IP3 
receptors (IP3R) located on the ER with the acinar cell.  The IP3R is a 
ligand gated ion channel, and binding of IP3 results in a conformational 
change that allows stored calcium ions (Ca2+) to flow from the ER into the 
cytoplasm.   This initial wave of Ca2+ release results in stimulation of 
ryanodine receptors to increase Ca2+ release from ER stores, resulting in 
a massive Ca2+ influx into the cytoplasm.  This apically restricted change 
in cytoplasmic Ca2+ concentration is required for the endpoint of zymogen 
granule exocytosis.  However, DAG also plays a role in zymogen granule 
exocytosis by activating PKC in acinar cells.   
For exocytosis of digestive enzymes to occur, the zymogen granule 
membrane must fuse with the apical cell membrane to allow release of its 
contents.  Membrane fusion is regulated by soluble N-ethylmaleimide-
sensitive factor attachment protein (SNAP) receptors, or SNAREs.  In the 
SNARE hypothesis, transport vesicles of secretory pathways are equipped 
with vesicular SNAREs (v-SNAREs) that interact with proteins on the 
target membrane (t-SNAREs) to enable membrane fusion and release of 
vesicular contents (reviewed in (Gaisano, 2000)).  The SNARE complex 
consists of three protein types; the vesicle-associated membrane protein 
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(VAMP) and SNAP proteins, both present on the vesicular membrane, and 
a plasma membrane localized syntaxin. Initial experiments involving the 
SNARE hypothesis were performed in bacterial and neuronal systems.  
However, non-neuronal SNARE proteins have been identified.  SNAREs 
postulated to be involved with apical exocytosis in pancreatic acinar cells 
include the t-SNARE syntaxin 2 and the v-SNAREs, VAMP 2 (Gaisano et 
al., 1994), VAMP 8 (Wang et al., 2004), and synaptobrevin 2 (Hansen et 
al., 1999) and synaptotagmin 1 (Falkowski et al., 2011).  
In pancreatic acinar cells syntaxin 2, which is anchored to the cell 
membrane is maintained in a closed conformation through association 
with mammalian uncoordinated-18 (Munc18).  When the cytosolic Ca2+ 
concentration increases, Ca2+ associates with Munc18, changing its 
conformation and dissociating it from syntaxin 2, allowing syntaxin 2 to 
remain in an open conformation that is receptive to interaction with v-
SNAREs.  The v-SNARE with which syntaxin 2 interacts is still 
unidentified, however, cleavage of VAMP2 using tetanus toxin resulted in 
a 30% decrease in Ca2+ stimulated amylase secretion (Gaisano et al., 1994), 
and knockout of VAMP8 abolishes secretagogue stimulated secretion 
(Wang et al., 2004) illustrating the importance of these proteins in the 
secretory process. Additionally, activation of PKCδ by DAG results in 
phosphorylation of VAMP2, synaptotagmin 1 and syntaxin, allowing for 
their association and subsequent fusion of the zymogen granule and cell 
membranes resulting in digestive enzyme exocytosis.  Therefore, PKCδ 
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provides a mechanistic link between acinar cell polarity and regulated 
exocytosis. 
1.2 « Pancreatitis»  
 
The exocrine pancreas is susceptible to numerous pathologies including 
cystic fibrosis, Schwachmann Diamond Syndrome, pancreatitis and 
exocrine pancreas cancers. Cystic fibrosis and Schwachmann Diamond 
Syndrome are characterized by genetic mutations in the cystic fibrosis 
transmembrane receptor (CFTR) (Kerem et al., 1989; Riordan et al., 1989; 
Rommens et al., 1989) and the Schwachmann-Bodian-Diamond-
syndrome (SBDS) (Nicolis et al., 2005) genes, respectively.  These two 
disorders are also the most common exocrine pancreas pathologies 
diagnosed in children, and result in exocrine pancreas insufficiency (Guy-
Crotte et al., 1996; Shwachman et al., 1964). Exocrine pancreatic cancer 
is predominantly diagnosed in adults, and often arises from ductal cells as 
pancreatic ductal adenocarcinoma. Other less predominant forms of 
exocrine pancreas cancer include, but are not limited to, acinar cell 
carcinoma, epithelial-derived papillary tumours, pancreatoblastoma, which 
is predominant in children.  Exocrine pancreatic cancer is often fatal due 
to late stage diagnosis arising from a lack of early detection mechanisms. 
However, a current predictor of pancreatic cancer is chronic pancreatitis 
(Lowenfels et al., 1993).  
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Pancreatitis, or inflammation of the pancreas, is a disease of the exocrine 
pancreas that can manifest in both acute and chronic forms.  Pancreatitis 
is a result of autodigestion, where pancreatic enzymes are prematurely 
activated within the tissue. As the disease progresses, infection may 
occur, resulting in organ bleeding and tissue necrosis.  Twenty percent of 
cases are severe, where pancreatic enzymes and toxins enter the 
bloodstream and cause sepsis and multi-organ failure.  As mentioned, 
pancreatitis can also be a precursor to pancreatic cancer. Statistics reveal 
that over approximately 200,000 and 50,000 Americans are hospitalized 
with acute or chronic pancreatitis respectively, with a mortality rate of 5-
20% depending on disease severity (Bank et al., 2002). 
Acute pancreatitis refers to a rapid-onset, reversible inflammation of the 
pancreas that can vary in severity from a mild, self-limiting form, to a more 
aggressive phenotype.  Chronic pancreatitis involves long-term 
inflammation, where tissue damage is irreversible.  In both situations, 
patients experience severe abdominal pain and swelling, accompanied by 
nausea and vomiting.  
1.2.1 «Etiology»  
Pancreatitis can arise from environmental or genetic factors. There are 
multiple environmental influences that can lead to development of 
pancreatitis, including the development of gallstones, and exposure to 
excessive ethanol or tobacco smoke.  The fact that not all people exposed 
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to ethanol or tobacco smoke develop pancreatitis indicates that there is a 
hereditary component to the disease.  Work from our lab has shown an 
increased sensitivity to ethanol exposure in mice lacking the exocrine 
pancreas transcription factor MIST1 (Alahari et al., 2011), illustrating an 
interaction between genetic and environmental factors.  Furthermore, 
other genetic factors associated with pancreatitis include mutations in 
genes encoding cationic trypsinogen (PRSS1), and serine protease 
inhibitor Kazal-type 1 (SPINK1).   
1.2.1.1 «Environmental Factors»  
Gall stones are the most common cause of pancreatitis in men and 
women (Yadav and Lowenfels, 2006).  The presence of a gallstone in the 
bile duct can obstruct drainage of pancreatic digestive enzymes, since the 
main pancreatic duct and bile duct both empty through the sphincter of 
Oddi.  Inability to properly clear digestive enzymes from the main 
pancreatic duct results in accumulation of digestive enzymes that can 
damage pancreatic tissue and lead to pancreatic inflammation.   
Other environmental risk factors include smoking and excessive alcohol 
consumption.  Most knowledge correlating smoking to pancreatitis is 
epidemiological, where there is a dose dependent response to tobacco 
smoke exposure and a synergistic effect with alcohol consumption 
(Lindkvist et al., 2008; Tolstrup et al., 2009; Yadav et al., 2009).  Little has been 
done to experimentally investigate the contribution of smoking to the 
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development of pancreatitis; however, one study showed that 58% of rats 
exposed to tobacco smoke for 12 weeks developed chronic pancreatic 
inflammation with fibrosis and scarring of acinar structures (Wittel et al., 
2006).   
The precise mechanism of alcohol-induced pancreatitis is still unclear, 
especially since not all heavy drinkers develop pancreatitis.  However, 
products of ethanol metabolism are thought to contribute to the 
development of pancreatitis.  The main site of alcohol metabolism is the 
liver, where ethanol undergoes oxidative metabolism to acetaldehyde and 
acetate (Badger et al., 2003).  The pancreas’ capacity for oxidative 
metabolism is much lower (Laposata and Lange, 1986) and uses an 
alternative metabolic pathway that converts ethanol into fatty-acid ethanol 
ester (FAEE) intermediates (Gukovskaya et al., 2002; Haber et al., 2004; 
Laposata and Lange, 1986).  When infused into rats, FAEEs cause a 
pancreatitis response with pancreatic edema, acinar cell vacuolization, 
intracellular trypsin activation (Werner et al., 2002) and induction of 
proinflammatory transcription factors (Gukovskaya et al., 2002).  
Additionally, cell stress pathways are activated after chronic exposure to 
ethanol in mice, and may contribute to observed acinar cell pathology.  
Specifically, administration of an ethanol diet in mice results in activation 




While there is a clear association of environmental factors and the 
development of pancreatitis, not all people chronically exposed to ethanol 
or tobacco smoke develop pancreatitis, intimating the involvement of a 
genetic component.  
1.2.1.2 «Genetic Factors»  
Hereditary pancreatitis is classified as an autosomal dominant condition 
that starts as bouts of acute pancreatitis, progressing to chronic 
pancreatitis, often at a young age.   Most patients with hereditary 
pancreatitis have one of two mutations (R122H or N29I) in the cationic 
trypsinogen gene (PRSS1) (Gorry et al., 1997; Whitcomb et al., 1996).   In the 
R122H mutation, arginine 122 is replaced with a histidine (Sahin-Toth and 
Toth, 2000) perturbing the Arg122-Val123 association that is required for 
degradation of prematurely activated trypsin in the pancreas (Sahin-Toth 
and Toth, 2000; Varallyay et al., 1998; Whitcomb et al., 1996). Further analysis 
revealed that this mutation increases the auto-activation and stabilization 
of prematurely activated trypsin (Kukor et al., 2002).  The N29I mutation 
results in the replacement of an asparagine residue with an isoleucine 
residue.  This mutation results in increased trypsinogen auto-activation 
without increasing its stability (Sahin-Toth and Toth, 2000; Szilagyi et al., 
2001; Teich et al., 2005).  Thus, the accepted mechanism of PRSS1 
mutations is uncontrolled trypsin auto-activation leading to tissue damage. 
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Mutation of a second gene, serine protease inhibitor Kazal-type 1 
(SPINK1), has also been linked to familial forms of chronic pancreatitis 
(Witt et al., 2000).  SPINK1 is a protease inhibitor that targets activated 
intrapancreatic trypsin.  The SPINK1 mutation, N34S, induces a 
conformational change that does not independently lead to pancreatitis.  
However, the N34S mutation is associated to alcoholic pancreatitis, 
indicating it is part of a larger pathological mechanism (Kuwata et al., 2002; 
Wittel et al., 2006).   
1.2.2 «Pathology»  
The pathology of pancreatitis includes inappropriate activation of 
zymogens, inflammatory response, dysregulation of Ca2+ and induction of 
endoplasmic reticulum (ER) stress.  
1.2.2.1 «Enzyme Activation»  
Acinar cells produce digestive enzymes that are synthesized and stored 
as inactive zymogens to prevent tissue autodigestion.  While a low level of 
intracellular zymogen activation takes place under physiologic conditions, 
protective intracellular mechanisms are in place to prevent cell damage, 
including the presence of trypsin inhibitors, proteases to degrade 
enzymes, and suboptimal enzyme activation pH.   
Even with these protective mechanisms in place, secretagogue 
hyperstimulation leads to intracellular enzyme activation.  Colocalization of 
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zymogen granules with lysosomes plays a role in this activation, where 
cathepsin B is redistributed from the lysosome to the zymogen granule 
and subsequently activates trypsin (Saluja et al., 1987; Watanabe et al., 1984). 
Treatment of isolated acini with cathepsin B inhibitors E-64d or CA-074me 
abolished trypsin activation associated with cerulein hyperstimulation 
(Saluja et al., 1997; Van Acker et al., 2002). Hyperstimulation of cathepsin B 
knockout mice with cerulein showed an 80% reduction in trypsin activation 
compared with wild type counterparts.  Parameters indicative of pancreatic 
damage, including necrosis, serum amylase and serum lipase, were also 
decreased in these animals (Halangk et al., 2000). 
The activation of trypsin and other enzymes is an early initiating event of 
pancreatitis, where trypsin activity is detected as early as 10 minutes after 
hyperstimulation with cerulein in rats, with detection of carboxypeptidase 
by 15 minutes (Grady et al., 1996; Mithofer et al., 1998).  Other hallmarks of 
pancreatitis, including cell vacuolization and edema, were detected within 
30 minutes of hyperstimulation, indicating that enzyme activation is an 
initiating event in pancreatitis.  The impact of enzyme activation on 
pancreatitis pathology is illustrated by the observation that pretreatment 
with protease inhibitors reduces the severity of pancreatitis in animals 




1.2.2.2 «Inflammatory Response»  
Unlike enzyme activation, the inflammatory response induced by 
pancreatitis is not an immediate response, occurring one hour after 
initiating experimental pancreatitis in mice.  During pancreatitis, acinar 
cells activate transcription factors that induce the production and release 
of various chemokines and cytokines that attract inflammatory cells (Grady 
et al., 1997).  The recruitment of various inflammatory cells potentiates 
expression of proinflammatory mediators including tumor necrosis factor 
(TNF) -?, and interleukins (IL) 1, 2 and 6 (Makhija and Kingsnorth, 2002).   
 
Platelet activating factor (PAF) is a proinflammatory mediator upregulated 
in secretagogue-induced pancreatitis (Sandoval et al., 1996; Zhou et al., 
1993; Zhou et al., 1990) as well as in human disease.  PAF has a role in 
wound healing, physiological inflammation and apoptosis (Liu and Xia, 
2006), and is produced by various inflammatory cells (Ishii and Shimizu, 
2000), as well as in pancreatic acini in response to cerulein (Ishii and 
Shimizu, 2000; Stafforini et al., 2003; Zhou et al., 1993).  The importance of 
PAF in pancreatitis pathology was illustrated when treatment with PAF 
antagonists resulted in decreased serum amylase levels, decreased cell 
vacuolization (Ais et al., 1992; Hofbauer et al., 1998; Lane et al., 2001) and 
decreased pancreatic inflammation (Lane et al., 2001) after hyperstimulation 




Substance P has also been implicated in the inflammatory response to 
pancreatitis.  Substance P is important for inflammatory processes 
(Bowden et al., 1994), and its expression is increased during cerulein 
induced pancreatitis, along with expression of it’s associated receptor, the 
neurokinin-1 receptor (NK-1R).  Mice lacking the NK-1R exhibited 
decreased severity of pancreatitis when hyperstimulated with cerulein 
(Bhatia et al., 1998), indicating that Substance P plays an important role in 
the pathogenesis of pancreatitis. 
 
One of the earliest immune response is the recruitment of neutrophils, 
which contribute to the pathogenesis of pancreatitis.  Neutrophil depletion 
resulted in decreased severity of cerulein induced pancreatitis in mice 
(Pastor et al., 2006).  The influence of neutrophils in the pathogenesis of 
pancreatitis is twofold.  First, the neutrophil’s NADPH oxidase system for 
generating reactive oxygen species contributes to trypsin activation and 
cellular necrosis.  This is evident in neutrophil depletion studies during 
pancreatitis where the cell death mechanism switches to apoptosis from 
necrosis (Pastor et al., 2006), and trypsin activation is decreased 
(Gukovskaya et al., 2002; Pastor et al., 2006).  Secondly, elastase produced 
by neutrophils proteolytically cleaves the junctional protein E-cadherin 
(Mayerle et al., 2005), allowing for neutrophil transmigration into the 
pancreas and inhibition of neutrophil elastase results in decreased 




1.2.2.3 «Dysregulation of Ca2+»  
The resting physiologic concentration of Ca2+ in the acinar cell cytosol is 
much lower than that found in the extracellular fluid and within intracellular 
Ca2+ stores (Petersen et al., 1998).  Due to this dichotomy, acinar cells are 
responsive to small increases in cytosolic Ca2+ concentrations, allowing 
Ca2+ signals to control intracellular events.  Regulated exocytosis initiated 
by CCK relies on a specific pattern of cytosolic Ca2+ oscillations, where 
short-lived spikes in the apical pole are followed by longer lasting 
transients that radiate throughout the cell.  Each of these oscillations 
associate with a burst of exocytosis and release of zymogens into the 
acinar lumen (Maruyama and Petersen, 1994).  Hyperstimulation of acinar 
cells, as seen in pancreatitis, results in a different pattern of Ca2+ release, 
where Ca2+ release is no longer restricted to the apical border, and 
physiologic oscillations are replaced by a large rise in Ca2+ followed by 
sustained elevation at a lower level.  
Pathologic Ca2+ release patterns occur early in the pathogenesis of 
secretagogue-induced pancreatitis.   Inhibition of hyperstimulatory Ca2+ 
elevations using Ca2+ chelators inhibits zymogen activation, illustrating a 
requirement for Ca2+ in premature enzyme activation (Kruger et al., 2000; 
Raraty et al., 2000; Saluja et al., 1999).  Additionally, pathologic activation of 
trypsinogen is attenuated in the absence of extracellular Ca2+, illustrating 
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that Ca2+ release from intracellular Ca2+ stores alone is not sufficient for 
enzyme activation (Kruger et al., 2000; Saluja et al., 1999).  However, 
cytosolic Ca2+ concentration alone is not sufficient for enzyme activation to 
occur, suggesting that other outcomes of secretagogue hyperstimulation 
also play a role in pancreatitis-associated trypsinogen activation (Raraty et 
al., 2000).   
 
1.2.2.4 «Induction of Endoplasmic Reticulum Stress»  
In mammalian cells, the endoplasmic reticulum (ER) serves as a site of 
protein folding, maturation and transport, and as a Ca2+ store. Pancreatic 
acinar cell function relies heavily on the ER for two reasons.  First, since 
acinar cells produce large amounts of secreted proteins, their ER must be 
able to process these proteins with high fidelity.  Secondly, proper 
zymogen secretion relies on changes in intracellular Ca2+, which occur, in 
part, through ER store operated Ca2+ release.   
 
In order for the ER to process secreted proteins efficiently, ER Ca2+ 
homeostasis must be maintained.  During pancreatitis, the prolonged 
increase in cytosolic Ca2+ results in depletion of ER Ca2+ stores and 
subsequent loss of ER homeostasis.  This results in ER stress, which 
occurs when there is an imbalance in ER protein handling.  A main 
outcome of ER stress is activation of the unfolded protein response (UPR) 
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to restore protein-folding homeostasis in the ER.  Our lab and others have 
shown that the UPR is activated during pancreatitis (Kowalik et al., 2007; 
Kubisch and Logsdon, 2007; Tashiro et al., 2001).   While activation of the 
UPR during pancreatitis may be clearly linked to ER Ca2+ homeostasis it is 
interesting to note that, in addition to restoring protein folding 
homeostasis, the UPR activates inflammatory responses, suggesting its 
involvement in contradictory outcomes related to pancreatitis pathology.  
Therefore, it is important to know what outcomes are specifically 
dependent on the UPR during pancreatic injury. 
 
1.3 « The Unfolded Protein Response»  
In eukaryotic cells, the lumen of the ER is the site of protein folding and 
maturation of secreted and transmembrane proteins.  The rate of unfolded 
protein entry into the ER can change rapidly based on the physiological 
state of the individual cell.  Secretory cells are required to be responsive to 
physiological and pathological stimuli that result in increased protein 
production and secretion.  For example, when pancreatic acinar cells are 
hormonally stimulated, they are triggered to produce and secrete digestive 
enzymes in quantities that exceed the capabilities of the maturation and 
folding machinery already present in the ER. Additionally, folding and 
maturation machinery require appropriate [Ca2+].  In instances where the 
protein-folding load of a cell is rapidly increased, cell signaling cascades 
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are activated to adjust the protein folding capacity of the ER to ensure that 
the quality of secreted and transmembrane proteins is maintained.  The 
unfolded protein response (UPR) is a set of three molecular cascades 
activated within the cell when its protein folding demand exceeds protein 
folding capacity.  Activation of the UPR eases the protein load on the cell 
through (1) inhibition of protein translation (reviewed in (Brostrom and 
Brostrom, 1998; Kaufman, 1999)) (2) increasing protein folding capacity 
through heightened synthesis of protein folding chaperones (Haze et al., 
2001; Okada et al., 2002) and increased production of lipids to expand ER 
compartments (Cox et al., 1997), (3) degradation of improperly folded 
proteins (Yoshida et al., 2003) and (4) activation of apoptosis (reviewed in 
(Schroder and Kaufman, 2005)). 
Three transducers of the UPR have been identified, and each mediates a 
distinct arm of the response.  These transducers are inositol-requiring 
protein-1 (IRE-1), activating transcription factor 6 (ATF6) and protein 
kinase RNA (PKR)-like ER kinase (PERK) (Figure 1.2).  The UPR 
transducers are localized to the ER membrane, where they have an ER 
luminal domain that senses accumulating unfolded and misfolded 
proteins, and a cytosolic domain that elicits appropriate signaling 
mechanisms to accommodate the sensed increased protein load.  The ER 
luminal domain associates with glucose responsive protein 78 (GRP78; 
BiP), which maintains the transducers in an inactive state.  There are two 
models describing activation of UPR transducers.  The first relies on 
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competition for BiP by accumulating of unfolded proteins in the ER lumen.  
Dissociation of BiP from the UPR transducers results in their activation 
and subsequent initiation of signaling cascades. The second model 
illustrates that transducer activation involves direct binding of unfolded 
proteins to its ER luminal domain of transducers (Gardner and Walter, 
2011).  This model is based on the observation that the IRE1 protein 
contains a groove for peptide binding (Credle et al., 2005), and that an 
IRE1 mutant incapable of binding BiP can activate signaling effectively 
(Kimata et al., 2007; Pincus et al., 2010). 
 
1.3.1 « Activating Transcription Factor 6 (ATF6)»  
ATF6 is a transcription factor synthesized as an inactive precursor 
localized to the ER membrane and contains a 272 amino acid ER luminal 
domain. While the luminal domain interacts with BiP as a sensor for 
accumulation of unfolded proteins, inter- and intramolecular disulfide 
bonds within this luminal domain act as redox sensors that monitor the ER 
environment (Walter and Ron, 2011).  Accumulation of misfolded proteins 
causes ATF6 to associate with transport vesicles and translocate from the 









Figure1.2.  The Unfolded Protein Response. The UPR consists of three 
pathways that are maintained in an inactive state by association with BiP.  
Activation of PERK, IRE1 and ATF6 results in co-ordination of numerous 
transcription factors that function to alleviate excess protein folding load in the 
ER by inhibiting translation, increasing expression of protein folding chaperones, 














































Sequential processing by site-1 protease (S1P) and S2P (Ye et al., 2000) 
results in the removal of both the ATF6 luminal and transmembrane 
domains (Haze et al., 1999; Ye et al., 2000), liberating the 378 amino acid 
N-terminal cytoplasmic domain (ATF6(N)).  ATF6(N) then translocates to 
the nucleus to activate transcription of UPR target genes including protein 
disulfide isomerase (PDI) to aid in protein folding, BiP, and the UPR 
transcription factor X-box binding protein-1 (Xbp1) (Lee et al., 2002).   
1.3.2 « Inositol Requiring Enzyme-1 (IRE1)»  
Of the three pathways, the IRE1 pathway is the most highly conserved 
throughout species, existing in all organisms studied to date, and initially 
discovered in yeast.  IRE1 has a bifunctional role as both a kinase and an 
endoribonuclease. The only known phosphorylation event mediated by 
IRE1 is trans-autophosphorylation of its juxtaposed kinase domains after 
oligomerization (Papa et al., 2003; Shamu and Walter, 1996).   
Trans-autophosphorylation activates IRE1’s endoribonuclease activity, the 
only known substrate for which is Xbp1 (Hac1 in yeast; (Calfon et al., 
2002; Yoshida et al., 2001)), which encodes X Binding Protein 1, a basic-
helix-loop-helix (bHLH) transcription factor.  IRE1 mediates 
endonucleolytic cleavage of a 26 base pair intron within Xbp1 mRNA.  
After excision, the 5' and 3' fragments are ligated by a yet unknown 
mechanism in metazoans, but appears to be similar to the mechanism in 
yeast where ligation occurs by tRNA ligase (Sidrauski et al., 1996).  Prior to 
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cleavage, translation of unspliced Xbp1 (Xbp1u) mRNA is results in the 
generation of a highly labile protein (Yoshida et al., 2006).  The cleavage 
event that generates spliced Xbp1 (Xbp1s) results in a frameshift mutation 
that shifts the stop codon and results in the translation of a more stable 
protein containing a nuclear localization signal and transactivation domain 
(Yoshida et al., 2001; Yoshida et al., 2006).  After translocation to the nucleus, 
XBP1 activates expression of a number of genes, including protein folding 
chaperones, genes involved in ER associated degradation (ERAD) and 
genes that regulate lipid biosynthesis, thereby stimulating ER expansion.  
In contrast, XBP1u acts as a negative regulator of the UPR by binding 
XBP1s and sequestering it from the nucleus, thereby inhibiting its 
transcriptional activation abilities (Yoshida et al., 2006).   
Events downstream of IRE1 oligomerization include binding of TRAF2 
(Urano et al., 2000).  The IRE1-TRAF2 complex can recruit multiple 
factors, including IκB kinase (IKK), and apoptosis signal regulating kinase 
1(ASK1).  Recruitment and activation of IKK results in phosphorylation 
and subsequent degradation of IκB, releasing nuclear factor-κB (NF-κB), 
which translocates to the nucleus (Hu et al., 2006).  The TRAF2-IRE1 
complex recruits ASK1, which further activates c-Jun N-terminal kinase 
(JNK) (Davis, 2000; Nishitoh et al., 1998).  Subsequent transcriptional 
regulation by both NF-κB and JNK plays a role in expression of 
inflammatory genes in conditions of cell stress and accumulated unfolded 
proteins (Urano et al., 2000).   
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1.3.3 « Protein Kinase RNA (PKR)-Like ER Kinase (PERK)»  
PERK is an ER resident transmembrane kinase that, when activated, 
oligomerizes and undergoes trans-autophosphorylation, much like IRE1.  
When activated, PERK phosphorylates elongation initiation factor 2α 
(eIF2α) at serine 51.  Phosphorylation of eIF2α inhibits general protein 
translation.  When eIF2α is not phosphorylated, the GTP-bound eIF2 
heterotrimer recruits Met-tRNA to the translational start site, allowing 
protein translation to proceed.  Once translation is initiated, GTP 
undergoes hydrolysis to GDP, leaving eIF2 in an inactive GDP bound 
form.  The eIF2Βε subunit of the eIF2B complex acts as a guanine 
nucleotide exchange factor (GEF) and is required to recycle eIF2 into its 
active, GTP bound form.  When eIF2α becomes phosphorylated at Ser51, 
it acts as a competitive inhibitor of eIF2Β, preventing reactivation of eIF2 
and a subsequent decrease in recruitment of Met-tRNA to translational 
start sites, resulting in a overall decrease in translation (Figure 1.3; 
(Harding et al., 1999)).  Decreased translation relieves the protein folding 
load for the cell and conserves amino acid pools for essential functions 
(Anthony et al., 2004; Zhang et al., 2002).  While general protein translation is 
repressed by the phosphorylation of eIF2α, mRNAs with small open 
reading frames (ORFs) in their 5' region are preferentially translated.  
Activating transcription factor 4 (ATF4) is one such mRNA that is 
preferentially translated. ATF4 regulates the expression of multiple UPR-
related target genes, including CCAAT/enhancer homologous protein 
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(CHOP)/Growth arrest and DNA-Damage-inducible 153 (GADD153) 
(Harding et al., 2000; Ma et al., 2002b), Growth Arrest and DNA Damage-
inducible 34 (GADD34) (Ma and Hendershot, 2003), Stanniocalcin 2 (STC2) 
(Ito et al., 2004) and Activating transcription factor 3 (ATF3) (Jiang et al., 
2004). 
CHOP/GADD153 is a basic leucine zipper (bZIP) transcription factor that 
is part of the apoptotic response of the UPR.  In most cells, CHOP is 
expressed at low levels, and increases only following induction of ER 
stress.  In addition to ATF4, ATF6 (Yoshida et al., 2000) and XBP1s can 
regulate Chop expression.  The responsiveness of Chop to all three 
factors is due to the presence of two amino- acid-regulatory elements 
(AAREs) (Bruhat et al., 2000) and two ER stress response elements 
(ERSEs) within the Chop promoter (Ubeda and Habener, 2000).  While 
ATF6, XBP1s and ATF4 can all bind the Chop promoter, ablation of the 
PERK pathway results in nearly complete ablation of Chop induction 
during ER stress, indicating that the PERK/ATF4 axis is required during 
stress conditions, and the other pathways are required for maximal 
induction of Chop (Harding et al., 2000; Okada et al., 2002; Scheuner et al., 
2001).  CHOP is a pro-apoptotic factor since it represses Bcl-2 expression 
(McCullough et al., 2001), allowing the increased Ca2+ flux from the ER into 










Figure 1.3.  Mechanism of translational Inhibition by the UPR.  Under normal 
conditions, the eIF2Bε subunit of the eIF2B complex recycles GDP to GTP on the 
γ subunit of eIF2.  GTP-eIF2 recruits met-tRNA to the translational start site and 
translation proceeds.  Induction of the UPR results in dimerization and activation 
of PERK, which then phosphorylates eIF2α at serine 51.  This phosphorylation 
event renders eIF2 a competitive inhibitor of eIF2B, resulting in decreased 
recycling of GDP to GTP on eIF2, decreasing the recruitment of met-tRNA to 










depolarization (Annis et al., 2001; Hacki et al., 2000).  This apoptotic 
mechanism occurs when other mitigating outcomes of the UPR have 
failed.    Protein phosphatase 1 regulatory subunit 15A (Ppp1r15a; or 
Growth arrest and DNA damage inducible (GADD34)) is an ER stress-
inducible factor.  ATF4 regulates expression of Gadd34 by binding to the 
unfolded protein response element (UPRE) that is upstream of the 
transcriptional start site (Gardner and Walter, 2011; Ma and Hendershot, 2003).  
When GADD34 is expressed, it acts as a regulatory subunit for protein 
phosphatase-1 (PP1c), which dephosphorylates eIF2α both in vitro and in 
vivo.  Thus, GADD34 acts as a negative feedback mechanism for the 
PERK pathway by mediating dephosphorylation of eIF2α and promoting 
re-initiation of general translation (He et al., 1996; Novoa et al., 2001).   
1.3.3.1 « Stanniocalcin 2 (STC2)»  
The stanniocalcin (STC) family of secreted glycoproteins consists of two 
members – STC1 and STC2 – that have 35% conserved identity and 
conservation of exon/intron boundaries, indicating that they are paralogs 
(Moore et al., 1999). STC was first discovered in fish and shown to be 
involved in Ca2+ homeostasis through effects on Ca2+ influx (Flik et al., 
1990; Sundell et al., 1992). Stc2 mRNA is expressed in a wide variety of 
mammalian tissues, including the heart, prostate, uterus, pancreas, and 
skeletal muscle (Gagliardi et al., 2005; Shin and Sohn, 2009). In mammals 
STC2 is undetectable in the circulation, thus STC2-related regulation of 
  
33 
Ca2+ is thought to take place at the cellular level.  Transgenic mice over-
expressing a human STC2 (STC2Tg) exhibit dwarf phenotypes (Gagliardi et 
al., 2005; Johnston et al., 2010) related to negative effects on bone and 
muscle development (41). Recent work with mice lacking Stc2 (Stc2-/-) 
identified STC2 as a negative regulator of Ca2+ influx into the cytosol from 
ER stores, and as an interactor with the ER Ca2+ sensor stromal 
interaction molecule 1 (STIM1)(Zeiger et al., 2011).  Additionally, STC2 
expression is upregulated upon induction of ER stress in N2a 
neuroblastoma cells (Law and Wong, 2009). This increase in STC2 
expression was reliant on the concomitant increase of ATF4 (Ito et al., 
2004).  While the exact function of STC2 in relation to the PERK pathway 
is unknown, studies using cultured fibroblasts isolated from Stc2-/- mice 
have revealed that STC2 expression is a prosurvival mechanism of the 
UPR (Zeiger et al., 2011).  To date, no relationship between PERK signaling 
and STC2 activation has been identified in vivo. 
1.3.3.2 « Activating Transcription Factor 3 (ATF3)»  
ATF3 is a bZIP transcription factor that belongs to the ATF/cAMP 
response element binding (CREB) family of proteins that bind to a core 
consensus sequence (TGACGT) in target promoters (Deutsch et al., 1988; 
Montminy and Bilezikjian, 1987).  ATF3 dimerizes at the leucine zipper motif 
to regulate transcription.  When homodimerized, ATF3 represses 
transcription of target genes, whereas heterodimerization can result in 
  
34 
different outcomes based on the binding partner.  Heterodimerization with 
CHOP results in the formation of an inactive dimer that cannot regulate 
transcription (Chen et al., 1996). However, association with c-Jun results in 
activation of a transcriptional program in neurons (Nakagomi et al., 2003; 
Pearson et al., 2003).   
The outcome of ATF3 acting as a transcriptional activator or repressor 
may be dictated by the isoform of ATF3 that is expressed or whether an 
ATF/CRE site is present in the promoter of the gene being regulated.  
ATF3 binds to promoter regions with ATF/CRE sites and stabilizes 
inhibitory cofactors resulting in gene repression.   
The discovery of various ATF3 isoforms has uncovered a role for ATF3 in 
transcriptional activation.  ATF3 isoforms lack the leucine zipper domain to 
varying degrees, resulting in finability to dimerize (Figure 1.4A). ATF3ΔZip 
was the first isoform to be identified and is the product of alternative 
splicing of the ATF3 gene. While full length ATF3 acts as a transcriptional 
repressor, ATF3ΔZip does not bind DNA and acts as a transcriptional 
activator  (Chen et al., 1994), which led to a cofactor model of ATF3 gene 
activation.  In this model,  ATF3 sequesters inhibitory cofactors from 
promoters, bypassing transcriptional repression (Chen et al., 1994; 
Hashimoto et al., 2002) (Figure 1.4B).  
 
Second and third ATF3 splice variants (ATF3ΔZip2a,b) were discovered in 









Figure 1.4. ATF3 Isoforms and Mechanisms of Transcriptional Regulation.  
A. ATF3 contains two activation domains (A), one repression domain (R), a basic 
region and leucine zipper (Zip).  The truncated ATF3ΔZip and ATF3ΔZip2 
isoforms lack the leucine zipper domain.  B. ATF3 represses transcription of 
genes containing ATF/CRE sites in their promoters by recruiting inhibitory factors 
(I).  ATF3 activates transcription at genes that do not contain ATF/CRE sites in 
their promoters by sequestering inhibitory factors.  Truncated ATF3 isoforms also 
sequester inhibitory factors to activate transcription.  Modified from (Chen et al., 
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ATF3ΔZip isoforms counteract transcriptional repression conferred by 
ATF3 (Hashimoto et al., 2002) (Figure 1.4).  ATF3ΔZip2c and ATF3ΔZip3 
were both identified in hepatocellular carcinoma (HepG2) cells during 
analysis for ATF3ΔZip2 expression, and while ATF3ΔZip2c conferred no 
transcriptional regulation ranscriptional transcriptional regulation in this 
system, ATF3ΔZip3 was able to stimulate transcription (Pan et al., 2003).  
However, the in vivo mechanisms by which ATF3 confers transcriptional 
regulation are still unclear.   
A recent study revealed that ATF3 recruits HDAC1 to the IL-6 and IL-12b 
gene promoters during ischemia/reperfusion injury in the kidney cell line 
NRK-52E (Li et al., 2010), providing a mechanism by which ATF3 confers 
transcriptional repression.   
Mice lacking Atf3 (Atf3-/-) exhibit no obvious phenotypes, consistent with 
the idea that ATF3 is a stress-inducible gene not required for normal 
physiological processes (Hartman et al., 2004).  Further studies with Atf3-/- 
mice revealed a role for ATF3 in numerous disease states where ATF3 
promotes apoptosis in cytokine stressed pancreatic islets (Hartman et al., 
2004), protects against cardiac hypertrophy, dysfunction and fibrosis 
(Zhou et al., 2011), and protects against ischemia/reperfusion injury in the 
kidney (Li et al., 2010). 
Three different lines of mice overexpressing ATF3 have been generated. 
Over-expression of ATF3 using the bovine keratin V (BK5) promoter 
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(BK5.ATF3), which promotes ATF3 expression in epithelial cells, leads to 
ATF3 accumulation in the epidermis, mammary gland, tongue, thymus, 
stomach and pancreas. BK5.ATF3 mice exhibit a sparse hair phenotype, 
and develop oral carcinoma (Wang et al., 2007) and  mammary 
metaplastic lesions or tumours (Wang et al., 2008) indicative of a role for 
ATF3 in cancer progression.       
ATF3 expression driven by the transthyretin (TTR) promoter (TTR-ATF3), 
increases accumulation in the liver and choroid plexus, but can also show 
expression in the endocrine pancreas. TTR-ATF3 mice experience 
perinatal lethality and die between 30 minutes and 4 hours after birth.  
After crossing founder mice with wild types and generating an ATF3 over-
expressing hybrid, it was determined that endocrine pancreas 
development was altered by inappropriate ATF3 expression.  The degree 
of the phenotype varied from one founder line completely lacking 
pancreatic islets, to other founder lines exhibiting decreased numbers of 
all pancreatic endocrine cells (Allen-Jennings et al., 2001).  Since TTR is 
also expressed in the liver, TTR-ATF3 mice exhibited liver dysfunction that 
resulted in decreased expression on phophoenolpyruvate carboxykinase 
(PEPCK), an enzyme involved in gluconeogenesis.  Inhibited expression 
of PEPCK in TTR-ATF3 animals resulted in hypoglycemia, contributing to 
the perinatal lethality of these animals(Allen-Jennings et al., 2002).   
Expression of ATF3 from the pancreas duodenal homeobox 1 (Pdx1) 
promoter (Pdx1-ATF3) targeted accumulation to developing islets and 
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pancreatic β-cells after birth. Pdx1-ATF3 mice experience early postnatal 
lethality and decreased overall size. These mice exhibited altered 
endocrine pancreas development, including smaller islet size, altered islet 
morphology and decreased numbers of insulin positive cells (Hartman et 
al., 2004).  
While it appears that extensive work has been aimed at determining the 
role of ATF3 in the endocrine pancreas, little is known about ATF3’s role 
in the exocrine pancreas. 
 
1.4 «Gene Transcription»  
Transcriptional regulation is a complex process whereby multiple 
factors determine expression of a gene.  While transcription factors, like 
ATF3, are thought to be important in the cell-specificity and developmental 
regulation of gene expression, other factors, such as transcriptional 
coactivators and corepressors are also critical to this process, in that they 
determine whether transcription will be activated or repressed at a given 
gene promoter.   
1.4.1 « Transcription Factors»  
Transcription factors are molecules that bind to promoters or 
enhancers of a given gene resulting in gene activation or gene repression. 
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The mechanisms through which transcription factors exert these 
influences include: 1) stabilization or inhibition of RNA polymerase II 
binding to the promoter or enhancer; 2) acetylation or deacetylation of 
core histones, which can be performed by the transcription factor itself, or 
by recruitment of histone acetyltransferases (HATs) or histone 
deacetyltransferases (HDACs); and finally, by 3) recruitment of 
transcriptional coactivator or corepressor molecules. 
1.4.2 «Gene Activation»  
Within chromosomes genes are packaged as nucleosomes, a structure 
where DNA is tightly wound around core histones.  The condensation of 
DNA in this manner serves as a level of transcriptional control in that, 
when condensed, DNA is inaccessible to transcription factors to promote 
transcription.   Activation of gene expression involves recruitment of 
transcriptional coactivators that fall into two distinct groups.  Histone 
acetyltransferases (HATs) function to acetylate conserved lysine residues 
in the amino terminal tails of core histones tails, neutralizing their positive 
charge and decreasing their affinity for DNA (Hong et al., 1993).  This 
leads to a relaxed DNA conformation that permits accessibility of 
transcription factors. Common HATs include CREB binding protein/E1A 
binding protein p300 (CBP/p300) and p300/CBP associated factor 
(PCAF).   
Unlike HATs, which target the histone amino terminal lysines, the 
second category of transcriptional coactivators destabilizes the core of the 
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histone via ATP-dependent mechanisms.  This results in a shift of the 
nucleosome, creating a nucleosome free area that exposes transcriptional 
enhancers to transcriptional activation (Hargreaves and Crabtree, 2011).  
Members of this class of transcriptional coactivators include 
Switch/Sucrose non-fermentable (Swi/Snf) and imitation switch (ISWI).  
Coincident with the discovery that histone acetylation is associated 
with transcriptional activation, was the discovery of the reverse 
mechanism where histone deacetylation results in transcriptional 
repression. 
1.4.3 «Gene Repression»  
The tightly wound nucleosomal structure results on repression of 
genes due to multiple different factors.  First, this condensed conformation 
disallows interaction of various proteins including transcription factors, 
polymerases, coactivators and corepressors with gene promoters 
(Workman and Kingston, 1998).  Second, chains of nucleosomes can 
become further folded into higher order structures that can repress entire 
chromosomal regions (Bell and Felsenfeld, 1999; Ramakrishnan, 1997).  
Finally, nucleosomes can interact with chromosomal proteins to further 
repress gene expression in a heritable manner (Grunstein, 1998).   
Further gene repression mechanisms involve the deacetylation of  
active gene promoter regions.  Histone deacetylation is carried out by a 
group of proteins called histone deacetylases (HDACs).  HDACs function 
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by removing the acetyl group from histone tails, leading to decreased 
space between histones and surrounding DNA and subsequent 
condensation of DNA resulting in inaccessibility of transcriptional proteins 
to gene promoters.     
There are three main classes of HDACs, that are defined by their 
cellular localization.  Of importance to this work are class I and class II 
HDACs.  Class I HDACs include HDAC 1, 2, 3 and 8, and are 
characterized based on their homology to the yeast RPD3 gene, their 
predominantly nuclear localization and their ubiquitous expression in 
human tissues.  Class II HDACs include HDAC 4, 5, 6, 7, 9, 10 and 11 
and are characterized by their similarity to the yeast HDA1, their nuclear 
or cytoplasmic localization, and their restriction to specific tissue types.  
Interestingly, HDAC1 has been linked to the UPR in that, in the kidney 
during ischemia-reperfusion injury, it associates with ATF3 to suppress 
transcription of inflammatory genes (Li et al., 2010)q.  While this is an 
intriguing finding, the role of HDACs and their association with ATF3 in 







1.5 « The Unfolded Protein Response and Pancreatic 
Physiology and Pathology»  
The role of the UPR in exocrine pancreas physiology and pathology has 
not been thoroughly investigated.  However, it is known that multiple UPR 
factors, including ATF4 and XBP1s are normally expressed in exocrine 
pancreas tissues during normal physiology. Development of a XBP1s 
reporter mouse where a variant of GFP is fused to XBP1s protein 
confirmed the presence of XBP1s in the exocrine pancreas under normal 
physiological circumstances (Iwawaki et al., 2004).   
Multiple knockout and transgenic mouse lines have been generated for 
different molecules involved in the UPR.  Only a few mutant mouse lines 
have been used to assess the role of the UPR in exocrine pancreas 
physiology and pathology, including mice lacking Xbp1 (Xbp1-/-), or Perk 
(Perk-/-).   
1.5.1 « XBP1 mutants»  
Xbp1 expression is first detected in the mouse pancreas at embryonic day 
(E) 12.5.  XBP1 expression peaks by E14.5, and then is reduced by E18.5 
(Clauss et al., 1993), suggesting a developmental role for XBP1.  A global 
Xbp1 knockout (Xbp1-/-) in mice is embryonic lethal with no viable Xbp1-/- 
embryos obtained after E14.5. Embryonic lethality was rescued when 
XBP1 was re-expressed in the liver (Xbp1-/-; LiverXbp1). Gross 
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morphological analysis of Xbp1-/-;LivXbp1 pancreata revealed a 90% 
decrease in pancreas size when compared to wild type (WT) littermates, 
and pancreatic tissue consisted of sparsely distributed acini in a loose 
mesenchymal structure.  Transmission electron microscopy (TEM) 
revealed proper organization of Xbp1-/-;LivXbp1 acinar cells around a lumen, 
but with significantly fewer and smaller zymogen granules compared to 
WT litter mates.  Additionally, the ER in mutant cells was poorly developed 
with few cisternae.  Pancreatic tissue from Xbp1-/-;LivXbp1 mice showed 
drastic reductions in amylase and trypsin accumulation and significant 
acinar cell apoptosis by E18.5 due to dysregulated ER stress (Lee et al., 
2005). Interestingly, development of the endocrine pancreas was 
unaffected in Xbp1-/-;LivXbp1 mice (Lee et al., 2005). Thus, this work 
established a role for XBP1 specifically in development of the exocrine 
pancreas.  
To more thoroughly determine the role of XBP1 in the pancreatic acinar 
cell, Xbp1flox (Lee et al., 2005) mice were crossed with a line that allowed for 
inducible cre-mediated recombination in pancreatic acini (Mist1-CreER/T2) 
to allow for inducible deletion of Xbp1 in adult acinar cells (Xbp1ΔEx2) (Hess 
et al., 2011).   Analysis of Xbp1ΔEx2 mice four weeks after loss of XBP1 
revealed a 60% decrease in expression of amylase and elastase, and 
increased activity of the UPR.  Structurally, Xbp1ΔEx2 acinar cells exhibited 
decreased accumulation of zymogen granules and decreased amounts of 
cytoplasm.  Further analysis revealed poorly developed and distended ER 
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with disorganized cisternae, and ribosomes were not longer associated 
with the ER. Additionally, these cells showed increases in ER stress 
indicators and eventually succumbed to apoptotic cell death, indicating 
that XBP1 is essential for maintaining both the UPR and acinar cell 
homeostasis (Hess et al., 2011). 
Transcriptional targets for XBP1 in the pancreas include Sec61α, ER 
degradation enhancer, mannosidase alpha-like (Edem), protein disulfide 
isomerase (PDI) and the pancreas-specific isoform PDIp.  Sec61α is 
required for translocation of newly synthesized proteins across the ER 
membrane (Rapoport et al., 1996), whereas EDEM plays a role in the 
degradation of misfolded proteins in the ER (Hosokawa et al., 2001).  As the 
name implies, the PDIs are required for disulfide bond formation and 
isomerization of newly synthesized proteins (Schwaller et al., 2003) within 
the ER. PDIp is exclusively expressed in the exocrine pancreas (Desilva et 
al., 1996) and is able to bind zymogens, suggesting an important role in 
zymogen folding (Volkmer et al., 1997).  XBP1 also directly regulates 
expression of Mist1, an exocrine pancreas transcription factor (Acosta-
Alvear et al., 2007). XBP1 binds to the Mist1 promoter in the C2C12 
myoblast cell line, plasma cells and in MIN6 insulinoma cells, and ectopic 
XBP1s expression induces MIST1 expression in these cells (Acosta-Alvear 
et al., 2007).  While these studies were not carried out in an acinar cell 
environment, they indicate that XBP1 can regulate expression of Mist1.    
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Studies have also aimed at determining XBP1’s role during pancreatic 
injury.  Experimental induction of pancreatitis using L-arginine in rats or 
CCK analogs in isolated rat pancreatic acini induced splicing of Xbp1 
(Kubisch and Logsdon, 2007; Kubisch et al., 2006).  Furthermore, studies from 
our lab and others have shown that prolonged exposure to ethanol 
initiated splicing of Xbp1 in pancreatic tissue (Alahari et al., 2011; Lugea et 
al., 2011).   While long-term ethanol feeding in mice does not lead to 
pancreatic deficiency, long-term ethanol feeding of Xbp1 heterozygote 
(Xbp1+/-) mice, which exhibit a 30% decrease in the level of pancreatic 
XBP1, resulted in areas of acinar cell necrosis, stroma deposition and the 
presence of tubular complexes.  There was also a 25% decrease in the 
number of zymogen granules per cell and a 30% reduction in amylase 
expression in Xbp1+/- ethanol-fed mice.  Other hallmarks of injury in 
Xbp1+/- mice included increased tissue inflammation, increased 
vacuolization of acinar cells and increased autophagy (Lugea et al., 2011).  
To date, transcriptional targets of XBP1 during pancreas injury have not 
been determined. 
1.5.2 « PERK mutants»  
Three different lines of Perk-/- mice exhibit a phenotype in the exocrine 
pancreas.  A single study revealed that global Perk knockout (Perk-/-) 
exhibited early postnatal lethality.  However, backcrossing into the outbred 
Swiss Webster strain resulted in decreased mortality and recovery of half 
of the predicted number of Perk-/- pups at weaning.  Exocrine pancreatic 
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tissue in Perk-/- mice displayed no gross morphological phenotype, 
however, closer inspection revealed ER that was segmented with 
distended lumens, indicative of impaired protein folding capabilities.  
Phosphorylation of eIF2α was significantly decreased in Perk-/- tissue, 
indicating that, under normal conditions, PERK is required for translational 
control in pancreatic tissue. Wild type mice exhibited limited fecal lipid 
content as assessed by Oil Red O staining, indicating that digestion was 
proceeding properly.  Perk-/- mice exhibited significant increases in fecal 
lipid accumulation, indicative of impaired digestion and exocrine 
insufficiency in digestive enzyme release. Additionally, Perk-/- exocrine 
tissue displayed increased apoptosis and increased cell proliferation.  
Taken together, these observations indicate that PERK plays a role in the 
maintenance of pancreatic acinar cell integrity (Harding et al., 2001). 
A conditional Perk-/- mouse with loxP sites inserted into intronic sequences 
flanking three exons that encode part of the luminal domain, the 
transmembrane domain, and part of the catalytic domain were crossed 
with mice carrying Cre recombinase driven by the adenoviral EIIa 
promoter (PKO).  Thirty seven percent of PKO mice survived perinatally 
and 23% of mice died prenatally.  Surviving mice exhibited 40-50% growth 
retardation by postnatal day (PN) 7 and eIF2α phosphorylation levels were 
reduced in the pancreata of these mice between PN7 and PN12. 
Pancreata of PKO mice are morphologically normal within the first three 
weeks of birth, but then begin to display an exocrine pancreatic phenotype 
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similar to the complete PKO mice with greatly distended and fragmented 
ER containing fewer proteins.  Over time, acinar cells became highly 
vacuolated and underwent massive apoptosis.  In addition, expression of 
digestive enzymes was impaired at the protein level but not the mRNA 
level (Zhang et al., 2002).   
Crossing PKO mice with mice expressing Cre recombinase driven by the 
elastase-1 promoter, generated mice with a PERK deletion exclusively in 
the exocrine pancreas (exPKO).  exPKO pups were indistinguishable from 
their littermates and at PN14 exhibited morphologically normal pancreata.  
By PN19 the discrete cell pockets in the exocrine pancreas of exPKO 
mice exhibited structural disorganization and cell death, where cells were 
swollen and degranulated with abnormal nuclei.  By 3-4 months of age, 
the normally predominant population of acinar cells was replaced by 
fibroblasts, adipocytes, macrophages and leukocytes.  Interestingly, these 
mice never became diabetic unlike their PKO counterparts, indicating that 
lack of PERK in the acinar cells specifically affects the exocrine pancreas.  
Interestingly, lack of PERK in acinar cells resulted in a pancreatitis like 
phenotype for a window of time, where pancreatitis associated gene 
expression is increased, followed by increased levels of serum amylase 
and cell apoptosis (Iida et al., 2007). 
1.5.3 « ATF4 mutants»  
To determine whether the phenotype observed in the exPKO mice was 
due to lack of ATF4 expression, the exocrine pancreas of mice lacking 
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ATF4 (Atf4-/-) was examined.  Atf4-/- mice exhibit retardation of postnatal 
growth and are blind due to defective lens development (Hettmann et al., 
2000; Masuoka and Townes, 2002).  Examination of the exocrine pancreas in 
Atf4-/- mice revealed a significant reduction in early postnatal exocrine 
pancreas development compared to wild type littermates.  Additionally, 
Atf4-/- exocrine pancreas tissue did not display upregulation of 
pancreatitis-associated genes, and did not exhibit increased cell death.  
These observations indicate that the observed phenotype in exPKO mice 
was not due to a lack of ATF4 upregulation (Iida et al., 2007).   
From these studies, it is clear that the PERK pathway is integral for both 
development and maintenance of the exocrine pancreas.  Loss of PERK 
results in a pancreatitis phenotype that is not explained by loss of ATF4. 
Another transcription factor in the PERK pathway that might play a role in 
the generation of exocrine pancreas pancreatitis phenotypes is ATF3.  As 
mentioned, Atf3-/- mice do not exhibit abnormal pancreatic development or 
progressive tissue degeneration.  However, ATF3 may play a role in the 
maintenance of the acinar cell phenotype under stress conditions in the 
exocrine pancreas. 
1.6 « Rationale»  
While it is known that the UPR is activated during pancreatic pathology, 
the specific UPR molecules involved in pathologic responses, and the 
roles of these molecules, are still unclear.  The goal of this study was to 
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determine the contribution of the PERK pathway to exocrine pancreas 
pathology and determine the transcriptional and molecular impact of the 
PERK pathways in this process.  
The hypothesis of this study is that the PERK pathway regulates the 
acinar cell response to injury through transcriptional and non-
transcriptional mechanisms.  To test this, I used two genetically modified 
mouse lines. Stc2Tg mice ubiquitously express the human STC2 protein 
while Atf3-/- mice contain a targeted deletion of the Atf3 gene.   
Both signaling molecules and transcription factors are assessed, providing 
a well-rounded perspective of the effects of PERK pathway activation in 
exocrine injury.  STC2 is a signaling molecule activated by the PERK 
pathway, and analysis of mice over-expressing STC2 will provide insight 
to how PERK pathway non-transcriptional mechanisms control exocrine 
injury.  ATF3 is a transcription factor that is activated by PERK signaling.  
Unlike other UPR transcription factors, ATF3 is not expressed during 
normal exocrine pancreas physiology; however, it is robustly upregulated 
during exocrine injury, implying that it’s sole role is in response to stress.  
ATF3 has been implicated in the differentiation program of various cell 
types, and may play an important role during pancreatitis since acinar 
cells are postulated to lose differentiation characteristics during injury. 
Thus, analysis of the role of ATF3 during exocrine pancreas injury may 
uncover a novel transcriptional role, not just for the PERK pathway, but for 
the UPR as a whole, in exocrine pancreas injury.   
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By characterizing Stc2Tg and Atf3-/- mice under normal and pathological 
conditions, I have been able to provide novel insight into the contribution 





Chapter 2  
2 « Over-expression of Stanniocalcin 2 alters PERK 
signaling and reduces cellular injury during cerulein 
induced pancreatitis in mice » 
This chapter is composed of a manuscript published in BMC Cell Biology (Fazio 
et al., 2011).  E. Fazio conceived experiments, performed >90% of the 
experimental work, provided theoretical input and wrote the manuscript.  G. 
DiMattia conceived experiments, revised the manuscript and provided theoretical 
input. S. Chadi performed the Stc2 Northern blot and K. Kernohan performed RT-
PCR reactions for Stc2 and Atf3, C.Pin conceived experiments, revised the 
manuscript and provided theoretical input. 
2.1 « Introduction » 
The stanniocalcin (STC) family of secreted glycoproteins consists of two 
members – STC1 and STC2 – that have 35% conserved identity and 
conservation of exon/intron boundaries, indicating that they are paralogs (Moore 
et al., 1999). STC was first discovered in fish and shown to be involved in calcium 
homeostasis through effects on calcium influx (Flik et al., 1990; Sundell et al., 
1992).  Although terrestrial mammals rarely experience hypercalcemia, 
alterations in subcellular compartmentalization of Ca2+ are found under 
pathological conditions such as the accumulation of improperly folded proteins. 
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STC2 expression is upregulated upon induction of hypoxic or endoplasmic 
reticulum (ER) stress in N2a neuroblastoma cells (Law and Wong, 2009). This 
increase in Stc2 expression was reliant on the concomitant increase of Activating 
Transcription Factor (ATF4) (Ito et al., 2004), a protein integral to (PKR)-like 
endoplasmic reticulum kinase (PERK) signaling, which is part of the unfolded 
protein response (UPR). To date, no relationship between PERK signaling and 
STC2 activation has been identified in vivo. 
 
The UPR is activated when ER homeostasis is disrupted. Alterations to proper 
functioning of ER machinery arise when protein load exceeds folding capacity, 
such as when luminal ER Ca2+ concentrations are perturbed. The UPR consists 
of three signaling pathways that are individually transduced by ATF6, inositol-
requiring enzyme 1 (IRE1) or PERK (Bertolotti et al., 2000; Okamura et al., 2000). 
Each transducer is maintained in a repressed state by binding of the ER 
chaperone protein glucose regulated protein 78 (GRP78/BiP) (Bertolotti et al., 
2000; Okamura et al., 2000). When unfolded proteins accumulate, they bind to 
GRP78/BiP resulting in its release from the UPR transducers (Freiden et al., 1992; 
Laitusis et al., 1999) . In the case of PERK, dissociation of GRP78/BiP leads to its 
homodimerization and autoactivation (Liu and Kaufman, 2003).  Activation of 
PERK results in phosphorylation of eukaryotic translation initiation factor 2α 
(eIF2α) (Shi et al., 1998), limiting its ability to contribute to the protein 
translational complex, thereby inhibiting global protein translation and alleviating 
the protein load on the cell (Harding et al., 1999). Phosphorylation of eIF2a also 
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selectively upregulates translation of mRNAs from short upstream open reading 
frames (Hinnebusch, 1997). The predominant target mRNA for peIF2α is Atf4, 
which subsequently increases the expression of the transcriptional repressor 
Atf3, and growth arrest and DNA damage-inducible (Gadd) 34 (Jiang et al., 2004; 
Ma et al., 2002a). GADD34 (alternatively known as Myd116; myeloid 
differentiation, primary response gene 116, or Ppp1r15a; protein phosphatase 1, 
regulatory [inhibitor] subunit 15A) negatively regulates PERK signaling by 
combining with protein phosphatase 1 to dephosphorylate eIF2α, thereby 
restoring general translation (Ma and Hendershot, 2003; Novoa et al., 2001).  
 
PERK is expressed in the exocrine and endocrine pancreas under normal 
conditions (Shi et al., 1998; Sood et al., 2000) and Perk-/- mice experience 
deterioration of glycemic control and exocrine insufficiency over time (Harding et 
al., 2001).  Exocrine specific deletion of PERK revealed cellular disorganization 
and degranulation, increased serum amylase levels and increased cell death 
(Iida et al., 2007).  Our laboratory identified rapid activation of PERK signaling 
following induction of pancreatitis by secretagogue hyperstimulation and 
correlated decreased activation of the pathway in mice that exhibit increased 
sensitivity to pancreatic injury (Kowalik et al., 2007).  Together, these 
observations indicate that PERK signaling has important roles in both the 




Given the relationship between PERK and STC2 in vitro, the objectives of this 
study were to (1) determine if a similar relationship exists in the exocrine 
pancreas and (2) gain insight into a role for STC2 as part of the UPR. Our results 
revealed a direct correlation of Stc2 expression with PERK signaling in vivo only 
after initiating pancreatic injury. Transgenic over-expression of human STC2 in 
mice (STC2Tg) (Gagliardi et al., 2005) resulted in altered PERK signaling and 
decreased signs of acinar cell damage associated with cerulein-induced 
pancreatitis (CIP). These observations indicate that STC2 is linked to PERK 
signaling in acinar cells and may have a role in limiting damage during pancreatic 
injury.  
 
2.2 « Methodology » 
2.2.1 « Mouse handling » 
For characterization of Stc2 expression during cerulein-induced pancreatitis 
(CIP), wild type and Mist1-/- mice were maintained on a C57/Bl6 background. For 
analysis of pancreatitis severity, STC2Tg and wild type mice are maintained on a 
C57/Bl6 x CBA background. Mice carrying a targeted ablation of the Mist1 gene 
(Mist1-/-) (Pin et al., 2001) or transgenic mice expressing the human STC2 
(STC2Tg) from the cytomegalovirus (CMV) promoter + chicken β-actin promoter 
(Gagliardi et al., 2005), have previously been described. All experiments were 
approved by the Animal Care Committee at the University of Western Ontario 
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(Protocol #116-2008) and mice handled according to regulations stipulated by 
the Canadian Council on Animal Care. 
 
2.2.2 « Induction of pancreatitis » 
To induce pancreatic injury, 2-4 month-old female mice were given up to seven 
hourly intraperitoneal injections of cerulein (50 µg/kg body weight; Sigma-
Aldrich). As a control, mice were injected with 0.9% saline. Mice were sacrificed 
1, 4 or 8 hours after initial cerulein injection and pancreatic tissue from each was 
immediately processed to isolate RNA, protein, and tissue sections for 
histological or immunohistochemical analysis. To assess serum amylase, blood 
was obtained via cardiac puncture, placed on ice for 20 minutes and centrifuged 
at 4°C, 2500 rpm for 15 minutes. Serum amylase was quantified using a 
Phadebas amylase assay (Magle Life Sciences, Lund, Sweden) as per 
manufacturer’s instructions. 
 
2.2.3 « Tissue preparation and histology » 
Pancreatic tissue was either directly embedded in OCT or incubated in formalin 
for 24 hours followed by paraffin embedding. For morphological analysis, paraffin 
embedded tissue was sectioned to 6 µM and stained with hematoxylin and eosin. 
Immunofluorescent (IF) analysis was performed on fresh frozen sections as 
described previously (Fazio and Pin, 2007). Primary antibodies and their dilutions 
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are listed in Table 1. Following primary antibody incubation, sections were 
incubated for 1 hour with the secondary antibodies of either anti-rabbit FITC or 
anti-mouse TRITC (1:250; Sigma-Aldrich). Sections were incubated with 4',6-
diamidino-2-phenylindole (DAPI; 1:1000) and slides mounted with Vectashield 
(Vector Laboratories, Burlingame CA, USA). Histological staining was visualized 
with a Leica DMIOS upright microscope and images were captured using 
OpenLab 4.0.3 Software (PerkinElmer, Waltham, MA, USA). 
 
2.2.4 « TUNEL analysis » 
TUNEL analysis was used to identify apoptotic cells using the In situ Cell Death 
Detection kit (Roche, Laval, QC, Canada) following manufacturer’s instructions.  
Briefly, frozen sections were fixed, washed and permeabilized before labelling 
with TUNEL reaction mixture for 60 minutes.  After washing, sections were 
counterstained with DAPI, coverslipped and visualized using a Leica DMIOS 
upright microscope and images were captured using OpenLab 4.0.3 Software 
(PerkinElmer, Waltham, MA, USA).  Analysis of percent apoptotic cells was 
carried out by comparing TUNEL positive cells to total cell number.  Cell counts 
based on DAPI were done using Image J software, and TUNEL positive cells 
were determined manually.  Ten random fields of view from 4 sections per animal 




2.2.5 « RNA isolation, Northern blotting and Real-Time RT-PCR » 
RNA was isolated from the splenic portion of the pancreas and processed using 
TRIzol (Invitrogen, Burlington, ON, Canada) as described (Kowalik et al., 2007). 
Northern blotting was performed as previously described (Pin et al., 2001). Thirty 
µg of RNA was resolved by electrophoresis on a 1% agarose/formaldehyde gel 
and blotted onto Hybond membrane (GE Healthcare, Baie d’Urfe, QC, Canada). 
Membranes were hybridized overnight at 42°C with a α-32PdCTP radiolabelled 
probe for Stc2 or for 18S rRNA as a loading control.  
For RT-PCR, two µg of RNA was reverse transcribed using Improm-II reverse 
transcriptase and random primers (Promega, Madison WI, USA). RT-PCR for 
Stc2, Atf3, amylase and b-actin was performed with 1 µL of cDNA and Taq DNA 
polymerase (Promega, Madison WI, USA). 
 
2.2.6 « Protein isolation and immunoblot analysis » 
Protein extraction was carried out to obtain both nuclear and cytoplasmic 
fractions.  Briefly, 5 volumes of buffer CE pH 7.6 (10 mm Hepes, 60 mM KCl, 1 
mM EDTA, 0.075% v/v NP-40, 1 mM DTT, 1 mMPMSF) were added to whole 
pancreatic tissue prior to homogenization.  Homogenized cells were centrifuged 
at 1000 rpm, 4°C for 4 minutes.  The supernatant was removed and saved as 
cytoplasmic extract.  The nuclear pellet was gently washed with CE buffer lacking 
NP-40 and centrifuged again.  After removal of the supernatant, the nuclear 
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pellet was covered with 1 pellet volume of NE buffer (20 mm Tris-HCl, 420 mM 
NaCl, 1.5 mm MgCl2, 0.2 mM EDTA, 1 mM PMSF, 25% w/v glycerol) and the 
NaCl concentration was adjusted to 400 mM for the entire volume.  An additional 
pellet volume of NE buffer was added followed by vortexing for resuspension.  
The extract was incubated on ice for 10 minutes with intermittent vortexing.  Both 
cytoplasmic and nuclear extracts were centrifuged at 14,000 rpm, 4°C, for 10 
minutes to pellet any debris.  Nuclear extracts were used for analysis of MIST1, 
PDX1, XBP1 and ATF4 levels, whereas cytoplasmic extracts were used for all 
other immunoblot analysis. 
For immunoblot analysis, 40 to 60 µg of pancreatic protein was resolved by 
SDS/PAGE and transferred to PVDF membrane (Biorad, Mississauga, ON, 
Canada). Blots were blocked with 5% non-fat dry milk (NFDM) and probed with 
primary antibodies diluted in 5% NFDM overnight at 4oC. For primary antibodies 
and their dilutions, see Table 2.1. Blots were washed three times in PBS 
supplemented with Tween-20 (PBS-T) then incubated with anti-rabbit or anti-
mouse horseradish peroxidase conjugated secondary antibody (1:10,000 or 
1:2000, Jackson Labs, Bar Harbor, ME, USA) in 5% NFDM for one hour. Blots 
were subjected to another series of washes in PBS-T, incubated with Western 
Lightning chemiluminescence substrate (Perkin Elmer, Waltham MA, USA), 
exposed to X-ray film (Fisher Scientific, Ottawa, ON, Canada) and developed. 
Denistometry was performed on immunoblot autoradiographs by analysis with a 
FluorChem 8800 documentation system and accompanying FluorChem 8800 




2.2.7 « Statistical Analyses » 
All statistical analyses were performed using Graphpad Prism 4.02 (Graphpad 
Software, San Diego CA, USA). Carboxypeptidase cleavage and serum amylase 
levels were analyzed using a two-way ANOVA followed by a Bonferroni post-hoc 
test.  Levels of phosphorylated eIF2α and LC3 cleavage were statistically 
analyzed using a Mann-Whitney test. 
2.3 « Results» 
2.3.1 « The PERK pathway, including STC2, is activated during 
cerulein induced pancreatitis» 
To determine if PERK signaling is active in pancreatic tissue, we performed IF 
with an antibody that recognizes only the phosphorylated form of PERK 
(pPERK).  The accumulation of pPERK was restricted to a tight apical portion of 
the acinar cells (Figure 2-1A) typical of where Ca2+ is released during the process 
of regulated exocytosis (Kasai and Augustine, 1990; Nathanson et al., 1992).  
Interestingly, CIP treatment led to a change in pPERK localization within four 
hours, with active PERK exhibiting a more diffuse and basally-restricted pattern 
of accumulation (Figure 2.1B). Increased accumulation of ATF3 protein was 
restricted to acinar cells in CIP-treated pancreatic tissue (Figure 2.1C, D).  RT-









Figure 2.1.  The PERK Pathway is Active in the Exocrine Pancreas During 
CIP. (A,B) Immunofluorescence (IF) for pPERK before (A) and 4 hours after (B) 
initiation of CIP.  pPERK (arrowhead) localizes to the apical end of acinar cells 
under physiological conditions and more basally during CIP.  Dotted line outlines 
an acinus.  Magnification bar = 13 µM.  DAPI was used to counter stain nuclei. 
(C, D) IF for ATF3 expression revealed limited accumulation before CIP (C) and 





Figure 2.1. The PERK Pathway is Active in the Exocrine Pancreas During CIP. 
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suggesting that PERK activation under these conditions does not lead to Stc2 
expression. Similar results were obtained in control pancreata for Atf3, another 
downstream target of PERK signaling.  Our laboratory has shown that PERK 
activity increases during pancreatic injury (Kowalik et al., 2007).  To determine if 
the pathological activation of PERK leads to increased STC2 expression, 
pancreatic injury was initiated by cerulein-induced pancreatitis (CIP). Increased 
Stc2 and Atf3 mRNA accumulation was observedduring CIP (Figure 2.2A). 
Increased Stc2 expression was confirmed by Northern blot analysis four hours 
after induction of pancreatitis (Figure 2.2B, saline WT vs. CIP WT). To support 
the link between elevated Stc2 levels and injury-associated PERK activation, we 
examined the expression of Stc2 in Mist1-/- mice, which exhibit minimal activation 
of PERK during injury (Kowalik et al., 2007). Mist1 is a transcription factor 
required for terminal differentiation of pancreatic acinar cells, and its absence in 
exocrine tissue results in improper activation of UPR components both normally 
and during injury via an unknown mechanism (Kowalik et al., 2007).  In sharp 
contrast to wild type mice, Stc2 mRNA was virtually undetectable upon CIP 
treatment in Mist1-/- (Figure 2.2B; Saline Mist1-/- vs. CIP Mist1-/-).   
2.3.2 « Pancreatic morphology is not altered in STC2Tg tissue» 
These findings suggest that STC2 is co-induced with PERK in acinar cells only 
after injury and may protect the pancreas in response to CIP.  To determine if 
STC2 could alter the acinar cell response to pancreatic injury, we examined a 









Figure 2.2. STC2 Accumulation Increases in Pancreatic Tissue Following 
Induction of Pancreatic Injury.  (A) RT-PCR of whole pancreatic RNA extracts 
from saline (S) and cerulein (C) treated mice showed increased accumulation of 
Stc2 and Atf3 mRNA after initiation of CIP in pancreatic tissue.  Amplification of 
Amylase (Amy) was used as a positive control for RT reactions. (B) Northern blot 
analysis revealed elevated Stc2 mRNA four hours after initial cerulein (CIP) or 
saline (S) injection.  No increases in Stc2 were observed in Mist1-/- (M-/-) 







   
Figure 2.2.  STC2 Accumulation Increases in 




(Gagliardi et al., 2005)).  IHC confirmed increased accumulation of STC2 in 
STC2Tg pancreata compared to wild type (WT) tissue, with STC2 accumulation in 
islets and exocrine tissue (Figure 2.3B).  H&E histology (Figure 2.3C, D) 
indicated that morphology was not overtly altered in STC2Tg pancreatic tissue. IF 
staining for pancreatic differentiation markers MIST1 (exocrine, Figure 2.4A, B) 
and PDX1 (endocrine, Figure 2.4C, D) showed similar spatial localization and 
GLUT-2 accumulation was localized to the cell membrane of endocrine cells in 
both genotypes (Figure 2.4E, F).    Western blot analysis confirmed equivalent 
levels of these markers, as well as amylase, between WT and STC2Tg tissue 
(Figure 2.4G).   
 
2.3.3 « Activation of the PERK pathway is altered in STC2Tg 
pancreatic tissue» 
We next examined PERK signaling in STC2Tg pancreatic tissue. PERK activation 
results in phosphorylation of eIF2α and translation of ATF4 (Lu et al., 2004; Vattem 
and Wek, 2004).  ATF4 is required for expression of Gadd34, Atf3 and Stc2 (Ito et 
al., 2004; Jiang et al., 2004; Ma and Hendershot, 2003).  Western blot analysis of WT 
and STC2Tg pancreatic tissue revealed decreased phosphorylation of both PERK 
and eIF2α (Figure 2.5A, B; n=4,animals p < 0.01) in STC2Tg tissue.  Surprisingly, 
ATF4 accumulated to higher levels in this STC2Tg pancreas, suggesting 









Figure 2.3.  Pancreatic Morphology is Unchanged in STC2Tg Mice.  (A, B) 
IHC for STC2 in WT (A) and STC2Tg (B) pancreatic islets shows that STC2 
accumulates in both acinar (*) and islet (I) tissue only in the STC2Tg mice. 
Magnification bar = 27 µm.   Tissue was counterstained with hematoxylin to 
reveal tissue morphology. (C, D) Hematoxylin and eosin staining comparing 
general histology of pancreatic tissue in WT (C) or STC2Tg (D) pancreata.  

















Figure 2.4. Analysis of Protein Expression in STC2Tg Pancreata.  IF analysis 
for MIST1 (A, B), PDX1 (C, D) or GLUT2 (E, F) in WT (A, C, E) or STC2Tg (B, D, 
F) pancreata.  Magnification bar  = 54 µm.  (G) Representative Western blot 











PERK and eIF2α appear reduced in STC2Tg tissue, we examined regulators of 
these two proteins.  The phosphorylation of eIF2α is reversed by GADD34 
through its interaction with protein phosphatase 1 (PP1) and recent evidence 
indicates that calcineurin binds PERK and stimulates its autophosphorylation 
(Bollo et al., 2010). In STC2Tg pancreatic tissue, the levels of GADD34 protein 
were significantly higher than wild type tissue (Figure 2.5C).  Conversely, STC2Tg 
calcineurin levels were considerably lower than WT counterparts.  No changes in 
the ER resident protein calregulin were observed between genotypes (Figure 
2.5C).  Based on these results, it appears that over-expression of STC2 affected 
expression of mediators and feedback mechanisms in PERK signaling. 
2.3.4 « Autophagy is enhanced in STC2Tg tissue» 
Alterations to PERK/ATF4 signaling should have an effect on cell autophagy, a 
long-term response to ER stress, which is regulated by ATF4 during hypoxia 
(Rzymski et al., 2010).  Western blot analysis followed by densitometry revealed 
a significant increase in the cleaved form of the autophagy marker myosin 
associated protein 1 light chain 3 (LC3) in STC2Tg pancreatic tissue (Figure 2.6A, 
B; n=4 animals, P < 0.01) consistent with increased accumulation of ATF4 in 
STC2Tg mice.  IF analysis corroborated increased autophagy as punctate LC3 
staining is notably increased in STC2Tg exocrine tissue (Figure 2.6C) when 











Figure 2.5.  Systemic Over-expression of STC2 (STC2Tg) Alters the PERK 
Signaling Pathway in Pancreatic Tissue. (A) Representative Western blot 
analysis for mediators of PERK signaling pPERK, peIF2α, total (t) eIF2α and 
ATF4 in wild type (WT) and STC2Tg (Tg), revealed decreased levels of pPERK 
and peIF2α and increased amounts of ATF4 in STC2Tg mice.  (B) Densitometry 
revealed that the ratio of peIF2a to total eIF2α is decreased in STC2Tg extracts 
relative to WT tissue (n=3 animals; *p<0.05).  (C) Similar western blot analysis 
revealed increased accumulation of GADD34 and decreased accumulation of 
calcineurin in STC2Tg pancreatic protein extracts.  No difference in calregulin 




Figure 2.5. Systemic Over-expression of STC2 
(STC2Tg) Alters the PERK Signaling Pathway in 
Pancreatic Tissue. 













































Figure 2.6. STC2Tg Acinar Cells Have Increased Autophagy. (A) 
Representative Western blot analysis for LC3 I and LC3 II accumulation in wild 
type (WT) and STC2Tg pancreatic extracts revealed increased accumulation of 
cleaved LC3 II which was (B) quantified by densitometry (n=3 animals; *p<0.05). 
IF for LC3 cellular accumulations showed increased autophagic vesicles 





Figure 2.6. STC2Tg Acinar Cell Have Increased Autophagy. 
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2.3.5 « Overexpression of STC2 results in decreased severity of 
exocrine cell injury» 
The alterations in PERK signaling and cell autophagy suggested that STC2Tg 
mice should have altered sensitivity to pancreatic injury. Four hours after the  
induction of pancreatitis, circulating serum amylase levels and tissue edema 
were compared between WT and STC2Tg mice (Figure 2.5). While serum 
amylase levels were moderately higher in saline-treated STC2Tg mice, the 
proportional increase in serum amylase levels following CIP was significantly 
lower in STC2Tg mice when compared to WT mice, indicative of decreased 
sensitivity to pancreatic insult (Figure 2.7A; n=4 animals, p < 0.05).  However, no 
difference was observed in tissue edema after CIP between genotypes (Figure 
2.7B).  We next examined the effects of pancreatic injury at the cellular level by 
examining enzyme activation and cell structures.  Western blot analysis of 
procarboxypeptidase (CPA) activation revealed reduced levels of active CPA in 
CIP STC2Tg pancreatic tissue when compared to WT cerulein-treated tissue 
(Figure 2.8).  Interestingly, analysis of cell junction proteins showed continued 
expression in STC2Tg tissue following CIP that was not evident in WT tissue. 
In WT acinar cells, the expression of β-catenin decreased to negligible levels, 
indicative of a loss in adherens junctions between acinar cells as expected 
(Figure 2.9A, B).  However, β-catenin remained readily detectable in STC2Tg 
pancreatic tissue after induction of CIP (Figure 2.9C, D).  Similarly, punctate 










Figure 2.7. STC2 over-expression reduces severity of acinar cell damage 
during cerulein-induced pancreatic injury. (A) Analysis of serum amylase 
levels four hours into CIP treatment show that serum amylase levels rise 
approximately 3 fold in WT mice when compared to saline (•) whereas the 
increase in STC2Tg mice is significantly lower at 2-fold (; * p < 0.01). (B) Tissue 
edema analysis revealed significant increases for both WT and STC2Tg tissue 4 
hours into CIP (black bars) when compared to saline controls (white bars; n=4 
animals).  No difference between genotypes was observed.  Error bars represent 






Figure 2.7.  STC2 Over-expression Reduces 
Severity of Acinar Cell Damage During 

































































Figure 2.8. During CIP STC2Tg Pancreata Exhibit Decreased Activation of 
Carboxypeptidase.  (A) Representative Western blot for procarboxypeptidase 
(47 kDa) and carboxypeptidase (CPA; 33 kDa) or trypsinogen four hours after 
initial saline (Sal.) or cerulein (CIP) injections showed decreased accumulation of 
activate CPA in STC2Tg mice four hours into CIP.  Quantification by densitometry 
(graph) comparing the ratio of cleaved (active; 33 kDa) to total CPA revealed a 
significant difference CPA activation between CIP treated WT and STC2Tg mice 
(n=4 animals; different letters indicate statistically different values; p<0.05).  
Trypsinogen levels do not differ between genotypes.  (B) Densitometric analysis 
revealed a significant increase in WT tissue, that was also observed in STC2Tg 
tissue, but to a lower and significantly different extent (n=4 animals, letters 




Figure 2.8. During CIP, STC2Tg Pancreata 
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Figure 2.9. Cell junctions are maintained in STC2Tg exocrine tissue during 
CIP.  IF analysis for β-catenin (A-D) or Cx32 (E-H) in wild type (WT) or STC2Tg 
(Tg) mice four hours after initial injection of saline (A, C, E, G) or cerulein (B, D, 
F, H) showing decreased accumulation only in WT tissue during CIP. (I) 
Representative Western blot analysis on pancreatic protein extracts 4 hours after 
initial saline or cerulein (CIP) injection confirm decreased β-catenin and Cx32 


























STC2Tg acini (Figure 2.9G, H) suggesting a greater disruption in gap junction 
complexes in WT acinar cells.  Western blot analysis corroborated IF data with β- 
catenin and Cx32 accumulations significantly lower in WT extracts compared to 
STC2Tg extracts four hours into CIP (Figure 2.9I) indicating that intercellular 
complexes were protected in STC2Tg mice, suggestive of reduced cellular 
damage.  Combined, these findings suggest that acinar cell integrity is 
maintained to higher degree when acini are exposed to higher than normal levels 
of STC2. 
Visualization of apoptosis using TUNEL staining revealed increased apoptosis in 
both WT (Figure 2.10A, B; arrowheads) and STC2Tg (Figure 2.10C, D; 
arrowheads) pancreatic tissue after induction of pancreatitis.  Quantification of 
TUNEL positive cells revealed decreased apoptosis in STC2Tg tissue that, 
although not statistically significant, may be of biological relevance (Figure 
2.10E). 
High mobility group protein b1 (HMGB1) is protein that translocates to the 
nucleus to interact with DNA, but upon necrotic stimulus, it is released from the 
nucleus and the cell to participate in inflammatory responses.  Cytoplasmic 
staining of HMGB1 is routinely used as an indicator of cell necrosis.  HMGB1 IF 
revealed the expected nuclear staining in both WT (Figure 2.11A) and STC2Tg 
(Figure 2.11C) saline treated tissue.  After induction of pancreatitis, punctate, 
cytoplasmic HMBG1 staining was observed in distinct patches of cells in WT 
tissue (Figure 2.11B).  All STC2Tg tissue analysed was devoid of punctate 











Figure 2.10. Apoptosis is Decreased During CIP in STC2Tg Tissue.  TUNEL 
analysis revealed an increase in apoptosis in both WT (A vs. B; arrowheads) and 
STC2Tg (C vs. D) pancreata after induction of pancreatitis (B, D) Magnification 
bar = 45 µM.  Quantification of TUNEL positive cells revealed a trend toward 
decreased apoptosis in STC2Tg tissue (I; n=4 animals; letters indicate significant 


















Figure 2.11. Necrosis is decreased during CIP in STC2Tg tissue.  HMGB1 IF 
to identify necrosis revealed expected nuclear localization in saline conditions for 
WT (A; n=3 animals) and STC2Tg (B; n=3 animals) tissue.  After induction of 
pancreatitis, patches of cells with cytoplasmic, punctate HMGB1staining, 
indicative of necrosis, were observed in WT tissue (C; n=4 animals) but not in 







Figure 2.11. Necrosis is Decreased During CIP in STC2Tg Tissue. 
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This analysis reveals that levels of both apoptosis and necrosis were decreased 
in STC2Tg tissue, indicative of less tissue damage after CIP. 
2.4 « Discussion» 
STC2 is a secreted protein that, when expressed to high levels in mice, has 
profound effects leading to growth restriction (Gagliardi et al., 2005).  However, 
ablation of Stc2 in mice results in limited phenotypic alterations suggesting that 
STC2 functions may fall outside normal physiology (Chang et al., 2008).   In 
support of such a hypothesis, in vitro analysis has identified increased Stc2 
accumulation following treatment with thapsigargin or tunicamycin, agents that 
activate ER stress pathways (Ito et al., 2004). STC2 is also up-regulated in 
response to hypoxic insult and is expressed to higher levels in many tumor-
derived cell lines (Law and Wong, 2009, 2010).  This suggests that STC2 may be 
involved in responding to external challenges that activate cell stress pathways. 
In this study, we have identified increased Stc2 accumulation within four hours of 
inducing pancreatic injury that correlated with activation of the PERK signaling. 
Importantly, forced expression of STC2 in mice altered PERK signaling and 
reduced cellular damage in response to pancreatic injury. These results suggest 
a role for STC2 responding to and mediating the effects of cell stress in 
pancreatic tissue. 
Studies assessing the expression of Stc2 have revealed a limited expression 
pattern in adult tissues. In the human pancreas, Stc2 is specifically expressed in 
alpha cells of the Islets of Langerhans and not in acinar tissue (Moore et al., 1999). 
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Our mRNA analysis revealed murine pancreatic expression of Stc2 only after 
induction of pancreatitis by secretagogue stimulation. Unfortunately, IHC on CIP-
treated tissue sections did not detect STC2 protein (data not shown) indicating 
that STC2 may be expressed at lower than detectable levels or that it is rapidly 
secreted into the circulation.  While we have not definitively identified acini as the 
cell origin of Stc2 expression, Atf3, a downstream mediator of PERK signaling, 
accumulated only in acinar cells during CIP.  Therefore, it appears that CIP 
treatment leads to a cell autonomous activation of Stc2. As observed in HEK293 
and N2a neuroblastoma cells, the increased accumulation of Stc2 is consistent 
with activation of PERK signaling in response to injury (Ito et al., 2004).   Induction 
of Stc2 mRNA levels was not observed after CIP in Mist1-/- mice, which do not 
activate PERK or ATF3, and experience increased severity of CIP (Kowalik et al., 
2007). These findings support the activation of Stc2 as a protective mechanism, 
potentially as a mediator of the UPR.  
While previous studies have correlated increased expression of STC2 as part of 
the UPR, the effects of STC2 on PERK signaling have not been examined.  We 
have now identified that systemically high levels of STC2 reduce PERK 
activation.  STC2Tg mice showed decreased phosphorylation of PERK and eIF2α 
in pancreatic tissue suggesting that continued exposure to STC2 may lead to 
activation of negative feedback mechanisms.  Since no change in total eIF2α is 
observed, this difference is peIF2α is specific to the phosphorylation event and 
not decreased eIF2α accumulation.   Similar analysis of total PERK levels would 




We have identified at least two effectors of the PERK signaling pathway that 
were changed in STC2Tg mice.  First, GADD34, which combines with protein 
phosphatase 1 to reduce eIF2a phosphorylation (Novoa et al., 2001), accumulated 
to higher levels.  Second, we observed significantly decreased accumulation of 
calcineurin, which stimulates PERK autophosphorylation, thereby increasing 
activity (Bollo et al., 2010).   Whether these changes are reflective of a direct role 
for STC2 in their regulation or a response to other events caused by over 
exposure to STC2 is unclear.  However, the altered expression of these factors 
suggests a role for STC2 in regulating Ca2+ homeostasis since both calcineurin 
and PERK are affected by altered Ca2+ sequestration in the ER. 
In light of decreased PERK and eIF2α activation, it was surprising that increased 
accumulation of ATF4 was observed in the pancreas of STC2Tg mice. 
Phosphorylation of eIF2a is known to stimulate translation of Atf4 mRNA, leading 
to increased ATF4 protein accumulation. However, increased ATF4 expression, 
and the subsequent increase in GADD34 could be mediated by increased 
stability of the ATF4 protein.  Recent studies have shown that ATF4 is stabilized 
by interaction with p300 through inhibition of ubiquitination (Lassot et al., 2005), 
and that association with p300/CBP enhances ATF4 transcriptional ability 
(Cherasse et al., 2007; Lassot et al., 2005).   It is possible that in STC2Tg mice, 
stabilization of ATF4 is enhanced regardless of decreased phosphorylation of 
eIF2α, accounting for its increased expression. Although there is little known 
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about non-peIF2α related transcriptional activation of ATF4, increased 
transcriptional activation by a yet to be identified factor cannot be ruled out.   
Figure 2.12 summarizes a potential role of STC2’s regulation of the UPR, where 
over-expression of STC2 directly or indirectly inhibits calcineurin expression, 
(Figure 2.12, dotted line), which then inhibits calcineurin-dependent 
phosphorylation of PERK.  Decreased phosphorylation of PERK results in 
decreased phosphorylation of eIF2α, as observed in STC2Tg pancreatic tissue.  
Although the increased expression of ATF4 in STC2Tg tissue is not intuitive 
considering the phosphorylation of both PERK and eIF2α, it reveals a potential 
direct or indirect role for STC2 in ATF4 regulation (Figure 7, dotted arrow).  This 
increase in ATF4 expression leads to increased GADD34 expression, which can 
then feedback and contribute to decreased phosphorylation of eIF2α. 
 
As would be expected from increased ATF4 expression, STC2Tg mice also 
exhibited an increased level of autophagy, a downstream consequence of 
elevated ATF4 levels.  Autophagy is important for maintenance of cellular 
homeostasis through balancing synthesis and degradation or recycling of cellular 
components. Independent studies have indicated that either phosphorylation of 
eIF2a or expression of ATF4 is required for induction of autophagy in vitro 













Figure 2.12.  Schematic Pathway Showing a Possible Role for STC2 in 
Affecting the PERK Signaling Pathway. The increased accumulation of ATF4 
leads to increased expression of GADD34, ATF3 and STC2. Elevated levels of 
STC2 can alter both PERK phosphorylation and ATF4 levels through as yet 
undetermined mechanisms (dashed arrows), as well as promote reduced 
damage during pancreatic injury. Whether this protective effect of STC2 is a 







Figure 2.12.  Schematic Pathway Showing a Possible 








PP1 + GADD34 
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The increased expression of ATF4 in STC2Tg pancreatic tissue may be the cause 
of increased autophagy.  Interestingly, we did not observe increased acinar cell 
apoptosis (data not shown), which is another downstream result of increased 
UPR. Therefore, it appears that only certain parts of the UPR have been 
activated in STC2Tg mice.    
Whether STC2 is protective in nature is still unclear since studies have shown it 
has both protective (Raulic et al., 2008) and detrimental roles (Law and Wong, 
2009, 2010) in cancer progression in vitro.  Our results suggest a protective 
advantage following exocrine pancreatic injury in vivo.  STC2Tg mice exhibit a 
decreased proportional increase in serum amylase levels, increased 
maintenance of cellular junctions, decreased apoptosis and necrosis and 
decreased activation of CPA in exocrine pancreatic tissue, all suggestive of 
decreased pancreatitis severity. In addition, the enhanced autophagy observed in 
STC2Tg acinar tissue would facilitate more rapid degradation of resident digestive 
enzymes upon injury, thereby limiting damage to cellular contents.  This would 
account for increased maintenance of cellular junctions.  However, to truly 
understand the role of STC2 in pancreatic injury, further experiments in mice 
lacking Stc2 mice should be performed.  
In conclusion, this is the first study to illustrate a link between the PERK signaling 
and STC2 in vivo, and suggests two novel roles for STC2, as a downstream 
effector of PERK signaling and possible protective factor during pancreatic injury.  
This is also the first time that STC2 has been shown to affect proteins that 
regulate Ca2+-mediated response in the cell.  
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Chapter 3  
3 « Stanniocalcin 2 affects endocrine pancreas structure 
and function » 
The experiments in Chapter 2 revealed a role for STC2 in the exocrine pancreas.  
While the exocrine and endocrine pancreatic compartments perform distinct 
functions, they are inextricably linked to one another, where dysregulation of one 
compartment can affect the other (Angelopoulos et al., 2005; Czako et al., 2009; 
Frier et al., 1976; Hardt and Ewald, 2011).  Since there was an observed 
alteration in exocrine pancreas function in STC2Tg mice, I sought to determine 
whether there was also an effect in the endocrine pancreas.  Additionally, STC2 
is a member of the PERK pathway which is important for endocrine pancreas 
development and function.  This chapter contains work to be submitted as a 
manuscript.  All experimental work in this chapter was performed by E. Fazio. G. 
DiMattia and C. Pin conceived experiments and provided theoretical input.  
 
3.1 « Introduction » 
STC2 is transcriptionally regulated by ATF4 and part of the PERK 
pathway within the UPR (Figure 1.2; (Ito et al., 2004)). PERK signaling is 
activated to alleviate protein folding overload in a cell and is largely 
associated with translational control and is important in cell types that 
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respond to stimuli associated with increased protein production and 
secretion, including pancreatic acinar and β-cells. PERK acts as a Ca2+ 
sensor in the ER of pancreatic β-cells, since it is activated under 
conditions that deplete ER Ca2+ stores (Cnop et al., 2007; Gomez et al., 
2008; Zhang et al., 2002).  PERK has been implicated in the maintenance 
and function of the endocrine pancreas, in that various mouse models 
lacking PERK expression (Perk-/-) exhibit symptoms congruent with 
Wolcott-Rallison syndrome (WRS) in humans.  Mice exhibit deterioration 
of endocrine pancreas structure and function and hyperglycemia with 
decreased levels of serum insulin (Harding et al., 2001).  Pancreatic islets 
in these mice degenerated over time, where insulin-producing β-cells 
underwent apoptosis and the normally peripheral glucagon expressing α-
cells began to populate the islet core (Harding et al., 2001; Zhang et al., 
2006).  
Recent work suggests that osteoblast specific factors can affect endocrine 
pancreas function (Lee et al., 2007; Yoshizawa et al., 2009) and that 
ablation of ATF4 in osteoblasts (Atf4osb-/-) results in improved glucose 
tolerance, increased islet insulin content, increased β-cell area and 
increased β-cell mass (Yoshizawa et al., 2009).  ATF4 also 
transcriptionally regulates Stc2, and mice over-expressing STC2 (STC2Tg) 
exhibit dwarf phenotypes (Gagliardi et al., 2005; Johnston et al., 2010) related 
to negative effects on bone development (41).  The fact that STC2 
regulates bone growth, and is a target of ATF4 transcriptional regulation 
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make it an attractive factor to examine in elucidating the effect of the 
PERK pathway on endocrine structure and function. 
Systemic over-expression of STC2 results in alterations to UPR signaling 
in the exocrine pancreas (Chapter 2).  However, the primary site of STC2 
mRNA production in humans is the pancreas (DiMattia et al., 1998; Moore 
et al., 1999) with STC2 protein specifically detected in alpha cells of 
pancreatic islets (Moore et al., 1999).  In addition, alterations in the UPR 
have adverse consequences in endocrine pancreas function that can lead 
to diabetes. Therefore, it is likely that STC2’s effects would not be limited 
to the exocrine compartment of the pancreas. 
The goal of this study was to determine if over-expression of STC2 affects 
endocrine pancreas structure and function.  While Stc2Tg mice do not 
exhibit hyperglycemia under resting conditions, glucose stimulated insulin 
secretion revealed decreased glucose tolerance in these animals.  
Morphological analysis revealed increased islet number and a decreased 
proportion of β-cells in STC2Tg pancreata. 
3.2 « Methodology» 
3.2.1 « Mouse Handling » 
STC2Tg and wild type mice were used as described in Section 2.2.1. 
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3.2.2 « Glucose Tolerance » 
Two to four month-old female mice were fasted overnight to determine 
resting blood glucose levels.  Following intraperitoneal administration of 2 
g/kg D-glucose (t=0), blood glucose levels were monitored at t=10, 20, 40, 
60, 90 and 120 minutes post-injection using tail blood with a Fast-Take 
Glucosemeter (Lifescan, Burnaby BC).  Mice were sacrificed using 95% 
CO2 and systemic blood collected via cardiac puncture.  Pancreata were 
dissected and processed for immunohistochemistry or protein extraction.  
Area under the curve (AUC) represents absolute glucose tolerance and 
was calculated for the glucose tolerance profile of each mouse using the 
trapezoidal method (Allison et al., 1995). 
3.2.3 « Morphological Analysis » 
Dual IF was performed with antibodies specific for insulin (Sigma, Oakville 
ON) and glucagon (Sigma, Oakville, ON).  Quantitative evaluation was 
performed using computer assisted image analysis with OpenLab 4.0.3 
Modular Software for Scientific Imaging (Improvision; Lexington, MA).  
Under low magnification the area of the pancreas was manually traced 
using Openlab software.  At a higher magnification, individual islets 
identified by insulin/glucagon staining were manually traced.  In total, three 
sections were chosen per animal with at least 10 islets counted.  Analysis 
parameters included total number of islets per unit area of pancreas, total 
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amount of islet area and number of insulin and glucagon positive cells 
(Fazio et al., 2005).  .  
 
3.2.4 « Statistical Analyses» 
Data are expressed as mean ± standard error. All statistical analyses were 
performed using Graphpad Prism 4.02 for Windows (GraphPad Software, 
San Diego CA). For comparison between two groups, the paired, Mann-
Whitney test was used, where significance was obtained if p < 0.05.   The 
glucose tolerance time course was statistically analysed using two-way 
repeated measures analysis of variance (ANOVA) and a Bonferroni post-
hoc test.  
3.3 « Results» 
3.3.1 « STC2 Expression Pattern» 
Since STC2 is a secreted protein, pancreatic accumulation was assessed 
through IF analysis, which revealed STC2 localization to islets in wild type 
tissue (Figure 3.1A).   Higher magnification revealed that STC2 protein 
was cytoplasmic (Figure 3.1B).  IF revealed increased accumulation of 
STC2 protein in the pancreatic islets of STC2Tg mice (Figure 3.1C) 
suggesting that the endocrine portion of the pancreas was a target for 
STC2 function.  Co-IF with insulin revealed STC2 expression in a subset 
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of β-cells in STC2Tg tissue  (Figure 3.1D).  Surprisingly, only low levels of 
STC2 were detected in the exocrine tissue in either situation. 
3.3.2 « Analysis of Endocrine Function» 
To assess whether exposure to high levels of STC2 affects endocrine 
function, the response of STC2Tg mice to increased glucose challenge 
was examined.  No significant difference in resting blood glucose levels 
was observed between STC2Tg and WT mice (Figure 3.2A, t = 0).  
Following IP injection of a 2 g/kg bolus of 50% glucose, STC2Tg mice 
showed a significantly different response in their ability to clear glucose.  
Blood glucose levels of WT and STC2Tg mice were similar 10 minutes 
after injection (t = 10).  However, by 20 minutes post- stimulation (t = 20), 
blood glucose levels of STC2Tg mice (29.0 +/- 2.7 mmol/L) were 
significantly elevated compared to WT counterparts (21.4 +/- 2.3 mmol/L).  
At 40 (WT: 18.1 +/- 3.3 mmol/L; STC2Tg: 28.0 +/- 4.1 mmol/L) and 60 
minutes post injection (WT: 13.0 +/- 2.1 mmol/L; STC2Tg: 21.7 +/- 3.4 
mmol/L) (t = 40, 60) the blood glucose levels of STC2Tg remained 
significantly higher than WT counterparts (*, p < 0.01; WT: n= 24, STC2Tg: 
n= 21).  By 120 minutes, blood glucose levels of WT and STC2Tg mice 
returned to baseline levels.  Area under the curve (Figure 3.2B), which 
represents absolute glucose clearance, was significantly higher in STC2Tg 
mice (*, p < 0.05; WT: n= 24, STC2Tg: n= 21) indicating a decreased 













Figure 3.1.  STC2 is Expressed in Pancreatic Islets. (A) STC2 is expressed in 
the islets of WT pancreata. (B) Magnification of boxed area in A illustrates that 
STC2 is cytosolic. Magnification bar = 5 µM. (C) STC2 expression is increased in 
the islets of STC2Tg mice.  (D) STC colocalized with insulin (red) in STC2Tg islets.  
DAPI stain was used to identify nuclei. Magnification bar for A,C,D = 16 µM.  Islet 















Figure 3.2.  Glucose Tolerance is Decreased in STC2Tg Mice.  STC2Tg mice 
exhibit significantly decreased glucose tolerance at 40 and 60 minutes post 
administration of glucose load (A;   = wild type,      = STC2Tg). (B) Area 
under the curve reveals overall significantly higher blood glucose levels in 






Figure 3.2.  Glucose Tolerance is Decreased in STC2Tg Mice. 
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3.3.3 « Analysis of Endocrine Pancreas Morphology» 
To determine whether decreased glucose tolerance was due to endocrine 
tissue defects, pancreatic morphology in STC2Tg mice was compared to 
that in WT mice.  No overt morphological differences were observed and 
STC2Tg acinar tissue showed no overt differences in morphology 
compared to WT mice (see Figure 2.3).  However, morphometric analysis 
indicated that STC2Tg mice had significantly more islets per unit section 
area (1.55x10-4 +/- 1.27x10-5;) compared to WT counterparts (1.06x10-4 +/- 
8.92x10-6) (Figure 3.3A; *, p < 0.05; WT; n = 5, STC2Tg: n= 5).  This 
difference was accompanied by a general trend in decreased islet size 
(WT: 7976 +/- 688 µm2; STC2Tg: 6939 +/- 922.5 µm2; Figure 3.3B) 
resulting in an overall increase in the percentage of endocrine area (WT: 
0.86 +/- 0.13 %; STC2Tg: 1.07 +/- 0.23 %; Figure 3.3C). Co-IF for 
glucagon (Figure 3.4A, B) and insulin (Figure 3.4C, D) revealed a similar 
localization pattern for both genotypes with glucagon positive α cells 
localized to the periphery of the islet. However, IF revealed a wider mantle 
of glucagon positive cells in STC2Tg mice (Figure 3.4A,B).  Quantification 
of the number of glucagon and insulin cells confirmed a significant 
increase in the number of glucagon expressing cells in STC2Tg mice 
compared to WT counterparts with a 69% increase in glucagon-
expressing cells, concomitant with a 20% decrease in insulin-secreting 













Figure 3.3. Islet Morphology is Altered in STC2Tg Pancreata.  There is an 
increase in islet number (A), with no change in islet size (B) resulting in an overall 





Figure 3.3. Islet Morphology 

























































Figure 3.4. Islet Composition is Altered in STC2Tg Mice. Glucagon expression 
is limited to the islet periphery in both WT (A) and STC2Tg (B) tissue.  Insulin is 
properly localized in both WT (C) and STC2Tg (D) tissue.  Cell counting revealed 
a significant increase in glucagon expressing cells (E) and a significant decrease 
in insulin positive cells (F) when compared to WT.  Magnification bar = 35 µM.  
















































Table 3.1).  Therefore, exposure to constitutively higher levels of STC2 
leads to altered endocrine function and morphology. 
3.4 « Discussion and Future Directions» 
Previous work identified alterations in the exocrine pancreas of mice 
overexpressing STC2.  In the study, analysis of the endocrine pancreas of 
STC2Tg mice revealed pancreas was also affected since the UPR has 
been shown to be required for differentiation and development of the 
tissue.  Thus, STC2Tg mice exhibit a bone (Johnston et al., 2010) and 
endocrine pancreas defect which have been previously linked in mice 
overexpressing ATF4 in osteoblasts (α1(I)collagen-ATF4).  These mice 
exhibit decreased glucose tolerance, decreased islet insulin content, 
decreased islet size and decreased β-cell mass, decreased insulin 
sensitivity and decreased insulin secretion (Yoshizawa et al., 2009), 
revealing a strong link between osteoblast specific ATF4 expression and 
endocrine pancreas function.  Assessment of endocrine function in 
STC2Tg mice revealed several of the same outcomes, which indicates that 
STC2 may be a mediator of the endocrine effects exhibited in the 
α1(I)collagen-ATF4  mice.  which is similar to the phenotype characterized 
in STC2Tg mice in this study. Assessment of insulin secretion and 
sensitivity in α1(I)collagen-ATF4 mice revealed that both are decreased.  
The link between ATF4 and STC2, and the fact that STC2 is a secreted 
glycoprotein lead to a theory that ATF4 expression in bone can lead to 
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increased STC2 production that is then secreted and may act in a 
paracrine or endocrine manner.  Thus, a potential mechanism is that ATF4 
activates synthesis and secretion of STC2 in order to inhibit insulin 
secretion once blood glucose homeostasis is achieved.  To validate this 
theory, insulin secretion and sensitivity should be measured in STC2Tg 
mice, and STC2 expression should be assessed in α1(I)collagen-ATF4 
and Atf4osb-/-  mice.  In addition, the endocrine compartment should be 
assessed in Stc2-/- mice.  
This work illustrates that within the pancreas, STC2 accumulates in islets.  
However, it is still unclear whether STC2 is produced in islets and acts 
locally, or whether the STC2 associates with islets via an endocrine 
mechanism.  Additionally, the mechanism by which STC2 alters the 
structure and function of pancreatic islets is still unclear.  While 
downstream signaling mechanisms of STC2 are unknown, exposure of 
islets to STC2 could result in an altered transcriptional program.   The 
STC2 transgene is detected as early as embryonic day 10.5 in STC2Tg 
mice (Gagliardi et al., 2005), which precedes the stage of pancreas 
development where endocrine cells begin to cluster into islet like 
aggregates. Exposure of endocrine tissue to STC2 during development 
could account for the decreased number of β-cells, increased number of 









Islet Parameter Examined WT STC2Tg Significance 
Islet Number/total section 
area 
1.06x10-4  ± 
8.92x10-6 
1.55x10-4  ± 
1.27x10-5* 
Yes, p<0.05 
Islet Size 7976  ± 688 µm2 6939  ± 922.5 µm2 No 
% Islet Area 0.86 ± 0.13  1.07 ± 0.23  No 
    
%  Glucagon Positive Cells 19.87 ± 1.81  33.63 ± 2.62* Yes, p < 0.005 
%  Insulin Positive Cells 80.54 ±1.91   64.56  ± 2.50* Yes, p < 0.001 
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alteration in islet cell proportion and size may result in decreased exocrine 
function observed in these mice, however, since STC2 plays a role in Ca2+ 
homeostasis, it’s possible that STC2 inhibits Ca2+ influx required for 
release of insulin from β-cells.  
The accumulation of STC2 in pancreatic islets also raises the question of 
how STC2 over-expression affects the exocrine pancreas.  Previous work 
(Chapter 2) outlined altered PERK pathway signaling in the exocrine 
pancreas, and a decrease in severity of pancreatitis in STC2Tg mice. While 
STC2 localization to the exocrine pancreas of STC2Tg mice was not 
detectable using immunofluorescence, immunohistochemistry revealed 
small pockets of STC2 localization to the exocrine pancreas that can 
account for the altered UPR and response to injury in exocrine pancreatic 
tissue in these mice.  However, the robust localization of STC2 to 
endocrine tissue suggests that cross-talk between the endocrine and 
exocrine compartments may be involved in altered exocrine pancreas 
responses in STC2Tg mice.  The influence of the endocrine component on 
the exocrine pancreas has been previously illustrated by the development 
of exocrine insufficiency during diabetes (reviewed in (Frier et al., 1976; 
Hardt and Ewald, 2011)).  For example, in the Cohen diabetic rat, 
nutritionally induced diabetes results in the accumulation of exocrine 
lesions and macrophage infiltration, lipid accumulation and acinar atrophy 
(Weksler-Zangen et al., 2008).  To determine whether exocrine effects are 
cell autonomous, primary cultures of acinar cells from STC2Tg mice can be 
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used to determine whether the levels of PERK activity decrease to levels 
consistent with normal, wild type, levels.  These cultures can also be used 
to determine whether the STC2Tg acinar cell response to hyperstimulation 
with CCK mirrors that which is observed in CIP-treated animals.  
Alternatively, islets from STC2Tg pancreatic tissue can be stimulated with 
glucose in culture to observe their glucose stimulated insulin secretion and 
address the possibility that primary effects in the exocrine pancreas affect 
endocrine pancreas function (Angelopoulos et al., 2005; Czako et al., 
2009).  
In conclusion, this study highlights a role for STC2 in endocrine pancreas 
structure and function, and suggests that STC2 is an endocrine mediator 





Chapter 4  
4 « Chromatin Immunoprecipitation (ChIP) from 
pancreatic acinar cells and whole pancreatic 
tissue » 
The first two results chapters delineated the outcomes of over-expressing a 
PERK mediator, STC2, in mice and the effects on pancreatic physiology and 
pathology.  While over-expression models may uncover important functions of a 
protein, they do not mimic the in vivo situation and may be misleading regarding 
the physiological relevance.  An alternative approach is to perform loss of 
function experiments with mediators of PERK signaling.  We have chosen to 
study ATF3, a transcription factor that can bind and affect gene expression. To 
appropriately assess ATF3 function, it was necessary to develop a protocol for 
chromatin immunoprecipitation (ChIP) from whole pancreatic tissue.  It was 
essential that I performed ChIP from whole pancreatic tissue since previous work 
from our lab indicated that the UPR is activated upon isolation of pancreatic acini.  
This characteristic was not desirable for the proposed studies since isolation-
related activation of the UPR could mask in vivo physiological events mediated 
by the UPR during pancreatitis.  The following is an excerpt from an article 
published in Pancreapedia (Fazio, 2011) an online database for researchers 
studying the exocrine pancreas.  E. Fazio designed ChIP from tissue 
experiments and wrote >80% of the manuscript.  R. Mehmood performed ChIP 
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from isolated cells and contributed to manuscript writing (not included here).  C. 
Pin provided theoretical input and revised the manuscript. 
4.1 « Introduction » 
Over the past decade, chromatin immunoprecipitation (ChIP) has emerged as an 
important technique for determining the binding of proteins to specific DNA 
sequences.  In particular, ChIP has been used to confirm whether transcription 
factors (TFs) work directly on target genes to promote gene activation or 
repression (reviewed in (Kuo and Allis, 1999)).  ChIP has advantages over other 
techniques that examine the role of TFs in regulating gene expression. Promoter 
assays that use reporter genes such as luciferase or green fluorescent protein 
(GFP) can determine whether a TF stimulates the expression of a certain 
promoter, but do not assess DNA binding to determine whether the effects on 
expression are direct.  Electrophoretic mobility shift assays (EMSA) can be used 
to determine TF binding but are relatively insensitive when compared to ChIP 
and require the ability of an antibody to supershift a protein/DNA complex to 
determine true interactions (Im et al., 2004).  
ChIP protocols have been adapted to study epigenetic modifications that affect 
gene expression and can be combined with Next-Generation sequencing (ChIP-
Seq) as a data output revealing previously unknown binding targets of proteins or 
epigenetic marks of interest (reviewed in (Park, 2009)).  The ability to obtain 
good quality starting material for ChIP analysis is crucial if scientists want to 
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apply changes in gene transcription and epigenetic modifications to the study of 
human disease. 
ChIP has become such a valuable tool that many companies have recognized a 
niche for ready-made ChIP kits, such as Millipore, Active Motif, Abcam and 
Pierce.  While these kits are useful for some tissue or cell types, they are not 
especially cost-effective and have proven to be insufficient for use with adult 
pancreatic tissue or isolated acinar cells.  After examining the efficiency and yield 
provided by a variety of ready-made ChIP kits, our laboratory has developed our 
own ChIP protocols for use with isolated acinar cells or whole pancreatic tissue.  
One of the benefits for using isolated cells for ChIP is that the acinar cells are 
purified from other pancreatic cell populations (Williams et al., 1978), thereby 
reducing any background that may be occurring with DNA targets of interest in 
non-acinar cells. However, the use of isolated acinar cells for ChIP can affect 
downstream analyses as a number of stress signaling pathways are activated 
upon isolation (Blinman et al., 2000; Johnson et al., 2009), and may obscure 
relevant endogenous mechanisms.  This becomes even more important if one is 
examining the transcriptional profile the tissue following the induction of cellular 
injury (i.e. pancreatitis).  Therefore, acinar cell isolation may mask the effects of 
actual disease mechanisms on the disease process. 
The following protocol was developed for ChIP analysis from whole pancreatic 
tissue.  While protocols exist for ChIP from various other tissues, none were 
adequate for use in the pancreas.  The pancreas presents a unique challenge 
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due to the high protein content, with the majority being proteases that may act to 
degrade TFs.  Therefore, a methodology for performing ChIP on pancreatic 
tissue either from untreated or pancreatitis models was established. 
4.2 « Preparation of Chromatin from Whole Pancreas » 
4.2.1 « Preparation of Nuclei from Whole Tissue» 
 
CIP was initiated as described in Section 2 and is a variation of the CIP model  
previously described (Niederau et al., 1990).  The pancreas was dissected and 
finely minced. Fine mincing is crucial for proper processing as a rougher mince 
proved to be unsuccessful for crosslinking and subsequent ChIP.  To cross-link 
protein to DNA, the minced pancreatic tissue was incubated in 40 mL of freshly 
made 1% formaldehyde in DMEM for 10 minutes at room temperature with 
rocking.  To quench the formaldehyde, glycine was added to a final concentration 
of 0.125 M and tissue was incubated for 5 minutes with rocking.  The tissue was 
pelleted by centrifugation at 95 x g for three minutes and washed with ice cold 
PBS containing aprotinin (5 µg/mL), leupeptin (5 µg/mL), pepstatin (5 µg/mL), 
and PMSF (75 µg/mL).  The pellet was resuspended in 1 mL of cold cytoplasmic 
lysis buffer (10 mM HEPES, 60 mM KCl, 1 mM EDTA, 0.075% (v/v) NP40, 1 mM 
DTT, 1 mM PMSF and protease inhibitors, the final pH was adjusted to 7.6) and 
homogenized with a loose pestle in a 7 mL glass Dounce homogenizer 
(Wheaton, Millville, NJ) until uniform.  The resulting lysate was centrifuged at 95 
x g at 4°C for 3 minutes to pellet nuclei.  The cytoplasmic supernatant was 
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removed, and the nuclear pellet resuspended in SDS lysis buffer (1% SDS, 10 
mM EDTA, 50 mM Tris, pH 8.1, and protease inhibitors) and incubated on ice for 
a minimum of 30 minutes.   The lysate was further homogenized using the tight 
pestle of the Dounce homogenizer and placed in a 1.5 mL centrifuge tube. 
 
4.2.2 « Preparation of Chromatin for IP » 
Sodium sarcosine was added to increase sonication efficiency (Acosta-Alvear et 
al., 2007) and was added to a final concentration of 0.5% (w/v) and the lysate 
split into 250 µL fractions. Suboptimal volumes for sonication can result in 
excessive sample frothing, which decreases sonication efficiency, or sample 
loss.  To shear DNA into 200-600 base pair fragments, samples were sonicated 
on ice once at level 4 for 20 seconds and four times at level 4 for 10 seconds 
using the Sonic Dismembrator 100. Efficient sonication parameters must be 
empirically determined for individual sonic dismembrators.  Our sonicator has a 
metal probe with a 3 mm tip and is optimal for shearing small volumes (0.1 to 50 
mL).  Between sonication, samples were left to incubate on ice. The resulting 
lysates were centrifuged at 4°C at 14,000 rpm for 10 minutes to remove debris. 
Sheared DNA samples should be stored at -80°C until use. 
It is best to assess shearing efficiency prior to immunoprecipitation.  To do so, 20 
µl of the sonicated chromatin was combined with 6 µl of 5 M NaCl and incubated 
overnight at 65oC, to reverse the cross-linking.  1 µl of proteinase K (5 mg/ml) 
was added to the reaction and incubated at 45oC for 1-2 hours.  Following phenol 












Figure 4.1.  Chromatin Shearing Efficiency.  Efficient shearing of chromatin 
from whole pancreatic tissue following cerulein (C) or saline (S) injection.  
Chromatin was sheared, crosslinks reversed and DNA resolved on a 1.5% 
agarose gel.  Proper shearing was indicated by a smear with highest intensity in 








µl H2O and 1 µl of RNase A (1 mg/ml). Following resolution on a 1.5% agarose 
gel, a DNA smear running from 200-600 bp was observed representing 
chromatin fragments (Figure 4.1).  
4.3 « Chromatin Immunoprecipitation (ChIP) » 
Each ChIP reaction requires approximately 50 µg of chromatin, but can be varied 
based on target protein abundance.   The appropriate amount of chromatin was 
combined with dilution buffer (20 mM Tris pH8.1, 1% Triton X-100, 1 mM EDTA, 
167 mM NaCl, protease inhibitors) to dilute chromatin 6-fold. The diluted 
chromatin was pre-cleared by incubating with protein A agarose (Millipore, 
Billerica, MA) for 1.5 hours at 4°C with rotating.  Beads were pelleted at 95 x g at 
4oC and the supernatant placed in a clean tube.  At this point, 12% of total 
chromatin used per IP was set aside as an input control.   Input samples are not 
required for each individual IP (per antibody) but are required per biological 
treatment or genotype (i.e. saline vs. cerulein).  One to 5 µg of antibody was 
added and IP reactions incubated overnight at 4°C with rotating.  As a negative 
control, an IP reaction using either similar IgG or an irrelevant antibody was 
used.  Inclusion of a positive ChIP control is beneficial in preliminary experiments 
to determine if the protocol is working.  The amount of antibody required for each 
IP varies depending on antibody quality and specificity.  We have successfully 
used rabbit anti ATF3 (Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit 
anti-spliced XBP1 (Biolegend, San Diego, CA) for ChIP from whole tissue.  
Rabbit anti-AcH3 (Millipore, Billerica, MA) has been used as a positive ChIP 
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control and Normal rabbit IgG (Millipore) as a negative control in both 
preparations (Figure 4.2).  After antibody incubation, protein A agarose beads 
were added and the reaction incubated for another two hours at 4°C while 
rotating to capture antibody:protein complexes.   Reactions were centrifuged at 
95 x g at 4°C for 3 minutes to pellet beads and the supernatant was removed 
using thin bore pipet tips.  Beads were run through successive washes for 10 
minute intervals at 4°C with rotating, using the following buffers containing 
protease inhibitors: a low salt wash (20 mM Tris pH 8.1, 0.1% SDS, 1% Triton X-
100, 2 mM EDTA, 150 mM NaCl), a high salt wash (20 mM Tris pH 8.1, 0.1% 
SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl), a LiCl wash (10 mM Tris pH 
8.1, 0.25M LiCl, 1% NP40, 1% Na deoxycholate, 1 mM EDTA), and, finally, two 
washes in Tris-EDTA (TE). The resulting beads were incubated in 75 µl of elution 
buffer (1% SDS, 100 mM NaHCO3) with rotating at room temperature for 15 
minutes.  Beads were pelleted and the eluent transferred to a new tube before 
repeating the elution procedure. The two eluents were pooled together and 
prepared for reversal of crosslinks.  To the corresponding input samples, 150 µl 
of elution buffer was added and reversal of crosslinks carried out by adding 6 µl 
of 5 M NaCl at 65oC for 4 hours to overnight. 1 µl RNase was added to the 
reaction at 37oC for 30 minutes, and the mix was incubated with 3 µl of 0.5 M 
EDTA, 6 µl of 1 M Tris-HCl (pH 6.5), and 1 µl of Proteinase K (5 mg/ml) at 45oC 














Figure 4.2.  PCR of ChIP Results.  Antibodies against acetylated histone 3 
(AcH3) or rabbit IgG (negative control) were used to determine the fidelity of the 
ChIP protocol on whole tissue.  PCR was performed using primers specific for 

















The DNA can be recovered by using either a PCR purification kit or by using 
phenol/chloroform extraction. We have successfully used Promega GenElute 
PCR purification columns (Fisher Scientific, Ottawa, ON) as per manufacturer 
specifications.  After purification, chromatin was eluted to 80 µL for use in 
downstream applications. If the preferred method of DNA extraction is 
phenol/chloroform, precipitate using ethanol and 10 µl of glycogen (5 mg/ml).  
Glycogen is required as a carrier since there may be only a small amount of DNA 
recovered.  Resuspend the DNA in 80 µl of H2O. 
The isolated DNA now can be used for ChIP-PCR or ChIP-qPCR. Depending on 
the recovery rate, the purified DNA is sufficient for library construction for Next 
generation sequencing and ChIP-on-chip or ChIP-seq.  If not being immediately 
used, isolated DNA can be stored at -20°C. 
 
4.4 « Analysis of DNA isolated from ChIP » 
ChIP DNA was also assayed using the GoTaq PCR Mastermix system 
(Promega, Madison WI).  Briefly, Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) promoter primers (Fwd: 5’ – CCCACACTTCTCCATTTCCC-3’ and 
Rvs: 5’- CCTCTCTTTGGACCCGCC-3’).were added to the GoTaq mastermix 
followed by addition of 2 µL of eluted DNA.  Using similar cycling conditions as 
listed above, samples were evaluated using an ABI Prism 7900HT Sequence 
Detection System and corresponding SDS 2.2.1 software (Applied Biosystems, 
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Foster City, CA).  Average Ct values for individual IPs and IgG controls are 
expressed as a percent of input (Mukhopadhyay et al., 2008).  The formula for 
quantification was adapted (Kernohan et al., 2010; Mukhopadhyay et al., 2008) 
as percent input = 100*((2^(ΔCtinput-ΔCtantibody))/input fraction)), where input 
fraction represents the amount of chromatin taken for input as a proportion of 
chromatin used for an individual IP.  For these experiments, the input fraction 




Chapter 5  
5 « Activating Transcription Factor 3 promotes the loss of 
the acinar cell phenotype by repressing Mist1 gene 
expression » 
While chapters 2 and 3 examined the role of the PERK signaling molecule STC2 
in the pancreas, development of a protocol for ChIP from whole pancreatic tissue 
allowed for analysis of PERK pathway transcriptional regulation in the pancreas.  
The PERK pathway contains multiple transcription factors, including ATF4, ATF3 
and CHOP.  ATF3 is unique in that it is not expressed under normal physiologic 
conditions on the exocrine pancreas, but is upregulated during exocrine 
pancreas stresses, identifying it as a purely stress response gene in this tissue. 
This chapter investigates the transcriptional role of ATF3 in the exocrine 
pancreas during pancreatitis.  This work is being prepared for a manuscript.  E. 
Fazio performed all experiments except for the immunohistochemistry on human 
pancreatitis samples, which was performed by C. Johnson. 
 
5.1 « Introduction» 
Pancreatitis is an inflammatory disease of the exocrine pancreas with 
significant morbidity and mortality associated with chronic conditions.  More than 
50,000 Americans suffer from chronic pancreatitis (CP) each year, and 
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individuals with CP are 53-fold more likely to be diagnosed with pancreatic 
adenocarcinoma (PDAC) (Lowenfels et al., 1997).  Recently, we have shown that 
loss of MIST1 expression is correlated with both CP and PDAC. MIST1 is a 
transcription factor required for complete acinar cell maturation (Pin et al., 2001) 
and an absence of MIST1 leads to increased acinar-duct-transdifferentiation, a 
process that may provide a link between CP and PDAC (Johnson et al., 2012). 
Therefore, it is critical to identify the factors that affect MIST1 expression.  
The unfolded protein response (UPR) is a series of molecular cascades 
associated with the endoplasmic reticulum (ER) activated by cell stress.  The 
UPR is triggered when protein-folding load within the ER exceeds folding 
capacity, leading to accumulation of unfolded or misfolded proteins.  Three 
distinct, yet complimentary pathways comprise the UPR, and are mediated by 
Protein kinase RNA (PKR)-like ER kinase (PERK); Activating Transcription 
Factor 6 (ATF6) and inositol-requiring protein-1 (IRE1).  
Activation of PERK results in phosphorylation of elongation initiation factor 
2α (eIF2α), leading to attenuation of translation for most proteins (Harding et al., 
1999).  When active, ATF6 translocates to the Golgi, where it is cleaved and 
subsequently shuttled to the nucleus where it activates genes associated with ER 
quality control (Haze et al., 1999; Yoshida et al., 2000).  Active IRE1 targets the 
X-box binding protein 1 (Xbp1) transcript, splicing out a 26 bp sequence that 
results in translation of an efficient transcriptional activator, spliced XBP1 
(XBP1s) (Yoshida et al., 2001), that targets genes responsible for protein folding 
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and degradation. The combined effects of UPR signaling reduce protein load in 
the cell.  
Abnormal activation of the UPR has been linked to a number of 
pathologies including Alzheimer’s disease, Parkinson’s disease, and various 
cancers (Bellucci et al., 2011; Hoozemans et al., 2007; Katayama et al., 1999; 
Kudo et al., 2002; Mahadevan and Zanetti, 2011; Sato et al., 2010; Sato et al., 
2000).  In the pancreas, the UPR has important roles in normal physiology and 
pathology, and is necessary for β-cell (Harding et al., 2001; Zhang et al., 2006), 
and acinar cell (Harding et al., 2001; Lee et al., 2005) function. Exocrine specific 
ablation of Perk results in tissue atrophy due to oncosis (Iida et al., 2007), while 
targeted deletion of Xbp1 leads to loss of acinar cells (Lee et al., 2005).  Under 
conditions that induce exocrine pancreatic injury, the UPR activity is markedly 
enhanced (Kowalik et al., 2007; Kubisch et al., 2006).  Similarly, chronic 
exposure to factors that increase susceptibility to pancreatitis, such as alcohol 
and high fat (Alahari et al., 2011; Lugea et al., 2011), leads to increased activity 
of the UPR.   However, it is unclear what molecular role the UPR has in the 
context of pancreatitis.   
Effects of the UPR are mediated by a number of transcription factors 
including ATF6, ATF4, ATF3, and XBP1s. Molecular analysis of the pancreas 
during cerulein-induced pancreatitis (CIP) revealed increased expression of 
genes involved in pancreatic development (Jensen et al., 2005), suggesting a 
loss of acinar cell differentiation characteristics. Previous studies have shown 
that XBP1s can regulate differentiation in both gastric zymogenic cells (Huh et 
  
131 
al., 2010) and cultured myoblasts (Acosta-Alvear et al., 2007), identifying a role 
for the UPR in cell differentiation.  However, XBP1s is expressed in mature 
acinar cells under normal physiological conditions, indicating it has roles outside 
of response to cell injury. 
An alternative stress response candidate is ATF3, a member of the 
ATF/CREB family of basic leucine zipper (bZIP) transcription factors, which binds 
to the unfolded protein response element (UPRE; (Deutsch et al., 1988)).  While 
many members of the ATF/CRE family are transcriptional activators, ATF3 
functions mainly as a repressor (Chen et al., 1994) and is expressed to negligible 
levels in mature acinar cells (Fazio et al., 2011).  Following multiple forms of 
pancreatic injury, including partial pancreatectomy, taurocholate induced 
pancreatitis, and CIP, ATF3 is rapidly and specifically upregulated in acinar cells 
(Allen-Jennings et al., 2001; Ji et al., 2003; Kowalik et al., 2007; Kubisch et al., 
2006).   
The goal of this study was to determine the relationship between ATF3 
and Mist1 during pancreatic injury.  Through chromatin immunoprecipitation 
(ChIP) and characterization of mice carrying a targeted ablation of Atf3 (Atf3-/-), 
we have uncovered a novel role for ATF3 in repressing Mist1 leading to loss of 
acinar cell differentiation.  ATF3 directly repressed Mist1 by recruiting Histone 
Deacetylase (HDAC) 5 to the Mist1 promoter. Importantly, increased ATF3 
accumulation was observed in samples from CP patients suggesting similar 
events contribute to the disease in humans. 
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5.2 « Methodology» 
5.2.1 « Mice and the induction of pancreatitis» 
Wild type (WT) and Atf3-/- mice were maintained on a C57/Bl6 background. Mice 
carrying a targeted ablation of the Atf3 gene (Atf3-/-) have been described 
(Hartman et al., 2004). All experiments were approved by the Animal Care 
Committee at the University of Western Ontario (Protocol #116-2008) and mice 
handled according to regulations stipulated by the Canadian Council on Animal 
Care.  To induce CIP, 2-4 month-old mice were given four hourly intraperitoneal 
injections of cerulein (50 µg/kg body weight; Sigma-Aldrich). As a control, mice 
were injected with 0.9% saline. To induce CP, mice received eight cerulein 
injections over a seven-hour span and this was repeated five times over 12 days.  
Mice were sacrificed either four hours after the initial cerulein injection, one hour 
after the final injection in the CP regime, or 3, 7 or 28 days following the last set 
of cerulein injections. Pancreatic tissue was processed for RNA, protein, tissue 
histology and chromatin from acute pancreatitis experiments or for tissue 
histology from CP experiments.  
 
5.2.2 « Tissue preparation and histology» 
Pancreatic tissue was directly embedded in OCT. Immunofluorescent (IF) 
analysis was performed on fresh frozen sections as described (Fazio and Pin, 
2007). Following primary antibody incubation, sections were incubated for one 
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hour in anti-rabbit FITC or anti-mouse TRITC secondary antibodies (1:250; 
Sigma-Aldrich). Sections were washed, stained with DAPI (1:1000) and mounted 
with Vectashield (Vector Laboratories, Burlingame CA, USA). Staining was 
visualized with a Leica DMIOS upright microscope and images captured using 
OpenLab 4.0.3 Software (PerkinElmer, Waltham, MA, USA). Human tissue was 
obtained following guidelines established by the University of Western Ontario 
and the Lawson Health Research Institute, and processed as described in REB 
#17012.  Paraffin sections were obtained from patients diagnosed with CP or a 
non-related disease and immunohistochemistry (IHC) performed as described 
(Alahari et al., 2011). An antibody specific for ATF3 was used (1:100; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA).  
 
5.2.3 « RNA isolation, Northern blotting and Real-Time RT-PCR» 
RNA was isolated from the pancreas and processed using TRIzol (Invitrogen, 
Burlington, ON, Canada) as described (Kowalik et al., 2007).  For RT-PCR, two µg 
of RNA was reverse transcribed using Improm-II reverse transcriptase and 
random primers (Promega, Madison WI). qRT-PCR for Mist1, Atf3 and 18S was 
performed using the GoTaq PCR Mastermix system (Promega). Reactions were 
performed using the BioRad CFX96 Touch Real-time PCR Detection System 
(BioRad Laboratories, Mississauga, ON, Canada) and data analyzed using CFX 




5.2.4 « Protein isolation and immunoblot analysis» 
Protein extraction, electrophoresis and immunoblotting were carried out as 
previously described (Johnson et al., 2004). For immunoblot analysis, 40 to 60 
µg of pancreatic protein was resolved by SDS/PAGE and transferred to PVDF 
membrane (Biorad, Mississauga, ON, Canada). Blots were probed with 
antibodies specific for MIST1 (ProSci Inc, Poway, CA, USA), ATF3 (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), and HES1 (Millipore, Billerica, MA, USA) 
followed by incubation with anti-rabbit or anti-mouse HRP-conjugated secondary 
antibodies (1:10,000 or 1:2000, Jackson Labs, Bar Harbor, ME, USA). Blots were 
processed with Western Lightning chemiluminescence substrate (Perkin Elmer, 
Waltham MA, USA), and visualized using the VersaDoc Imager and Quantity 
One Software (BioRad, Mississauga, ON, Canada).   
 
5.2.5 « Chromatin Immunoprecipitation» 
Pancreatic tissue was dissected from CIP or saline-treated WT and Atf3-/- mice, 
chromatin isolated, and chromatin immunoprecipitation (ChIP) was performed as 
described in Chapter 4. Following chromatin isolation, antibodies specific for 
ATF3 (Santa Cruz Biotechnology, Santa Cruz CA, USA), HDAC1 (Active Motif, 
Carlsbad, CA, USA) and HDAC5 (Active Motif, Carlsbad, CA, USA), or rabbit IgG 
(Millipore, Billerica, MA, USA) as a control, were used to IP protein/DNA 
complexes. DNA was recovered using Promega GenElute PCR purification 
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columns (Fisher Scientific, Ottawa, ON, Canada) as per manufacturer 
specifications.  After purification, chromatin was used for PCR and qPCR. 
 
5.2.6 « Statistical Analyses» 
All statistical analyses were performed using Graphpad Prism 4.02 (Graphpad 
Software, San Diego CA, USA). Analysis of Mist1 and Atf3 expression in WT 
pancreatic tissue following CIP was performed using an unpaired t-test.  
Comparisons of apoptosis, ChIP occupancy and Mist1 and Atf3 expression 
between CIP or saline-treated WT and Atf3-/- mice was performed using a two-
way ANOVA with a Bonferroni post-hoc test. 
 
5.3 « Results» 
5.3.1 « Acinar Cell Differentiation During Pancreatitis» 
To determine the effects on cerulein-induced pancreatitis (CIP) on the 
maturation state of acinar cells, cell junctions were assessed by IF analysis 
(Figure 5.1).  Within four hours of initial cerulein injections, Zona occludens 1 
(ZO1), a component of tight junctions, was completely lost from the apical 
borders of acinar cells (Figure 5.1A,B).  Disruptions in β-catenin (adherens 
junctions) and connexin 32 (Cx32; gap junctions) accumulation were also 
observed (Figure 5.1C,D and E,F respectively).  Disruptions of cell junctions 
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suggested effects on polarity (Adamo et al., 2001).  Therefore, the localization of 
atypical protein kinase C ζ (PKCζ), which interacts with partitioning proteins 
(PAR) 3 and 6 to establish cell polarity (Izumi et al., 1998), was assessed.  
Similar to β-catenin, PKCζ localization was disrupted within four hours of initiating 
CIP. The normal apical localization of PKCζ was replaced by diffuse basal 
localization indicative of aberrant cell polarity (Figure 5.1G,H).  Western blots of 
whole pancreatic extracts (Figure 5.2) confirmed decreased expression of Cx32 
and β-catenin, and not simply a redistribution of protein within the cell.  
 
The loss of cell polarity, on its own, does not indicate a loss of acinar cell 
differentiation.  Therefore, the expression of transcription factors that affect 
acinar cell differentiation was examined.  Hairy and Enhancer of Split (HES) 1 is  
part of the Notch signaling pathway that defines exocrine precursor cells, and 
HES1 re-expression in acinar cell explants induces dedifferentiation (Miyamoto et 
al., 2003).  Western blot analysis of whole pancreatic protein revealed increased 
HES1 expression one and four hours into CIP relative to saline controls (Figure 
5.2A) indicating acinar cells reactivated developmental genes during pancreatitis.  
Conversely, the expression of MIST1 was dramatically reduced in acinar cells 
concomitantly.  IF confirmed a loss of nuclear MIST1 accumulation 4 hours into 
CIP (Figure 5.2B,C).  The decreased expression of MIST1 was due to reduced 












Figure 5.1.  Acinar Cell Differentiation Characterisitcs are Disrupted During 
CIP.  IF for zona occludens (A, B; ZO1), β-catenin (C, D), Connexin32 (E, F; 
Cx32) or PKCζ (G, H) in saline (SAL) or cerulein (CIP) treated pancreatic tissue.  
Individual acini are outlined and the apical lumen indicated with *.  Punctate 
staining representing Cx32 is indicated with an arrow.  Nuclei are identified with 

























Figure 5.1. Acinar Cell Differentiation Characteristics 










Figure 5.2.  Cell Differentiation is Lost During Pancreatitis. (A) Western blot 
analysis for β-catenin, Cx32, HES1 and MIST1 one, four and eight hours after 
initial saline (SAL) or cerulein (CIP) injection.  GLUT2 was used as a loading 
control. IF for MIST1 four hours into saline (B) or cerulein (C) treatment. * 
indicates an islet.  Magnification bar = 35 µm.  (D) qRT-PCR for Mist1 four hours 
into saline or cerulein treatment. Mist1 RNA levels were normalized to β-actin.  

























5.2D).  These results support a model in which acinar cell differentiation 
characteristics are repressed early in CIP.  However, the actual mechanism of 
how this occurs is unknown.   
 
5.3.2 « Activation of UPR Transcription Factors During CIP» 
 
We next examined the accumulation of transcriptional regulators involved in the 
UPR.  Western blot and IF confirmed increased accumulation of XBP1s, a known 
transcriptional activator of Mist1, one to eight hours into CIP (Figure 5.3A-E). In 
addition, analysis of ATF3, a known transcriptional repressors in the UPR, 
revealed a dramatic increase 4 hours into CIP at both protein (Figure 5.3A) and 
mRNA levels (Figure 5.3F) relative to saline conditions where ATF3 was not 
detected.  Since many pathways are activated during CIP, to determine the effect 
of UPR activation alone in MIST1 expression, mice were treated with the direct 
UPR inducer, tunicamycin (Zinszner et al., 1998).  Activation of the UPR alone 
resulted in decreased MIST1 expression (Figure 5.4), specifying a role for the 










Figure 5.3.  UPR Transcription Factors are Upregulated During CIP.  (A) 
Representative western blots for XBP1 and ATF3 pancreatic protein extracts 
one, four and eight hours after induction of pancreatitis.  Total (t) eIF2α was used 
as a loading control. Immunofluorescence reveals that nuclear expression of 
XBP1 is increased as early as 1h into CIP (C) and persists at up to 8h after CIP 
(D, E). Magnification bar = 30 µM. (F) QRT-PCR analysis for Atf3 mRNA 
normalized to β-actin four hours after initial saline or cerulein (black bar) injection. 














Figure 5.4. Direct Activation of the UPR Results in Decreased MIST1 
Expression. Mice were sacrificed 8 hours after a single injection of tunicamycin 
or a dextrose control.  Phosphorylation of PERK (p-PERK) and expression of 
XBP1 were both increased after tunicamycin treatment, indicative of activation of 
the UPR.  Expression of MIST1 was decreased after injection of tunicamycin, 
indicating that the UPR is sufficient for decreased MIST1 expression.  Amylase 


















5.3.3 « ATF3 Expression During Chronic Pancreatitis» 
Recently, we identified a loss of MIST1 accumulation in acinar cells of CP 
patients (Johnson et al., 2012). To determine if the relationship between MIST1 
and ATF3 extended to CP, we first examined expression of these factors in a 
mouse model of CP that involves repeated induction of acute CIP, by extending 
cerulein injections over a period of two weeks. IF confirmed an inverse 
correlation between ATF3 and MIST1 accumulation. By Day 28 after the final 
cerulein injection, ATF3 was limited to focal pockets within the acinar tissue.  
Interestingly, these same regions showed limited MIST1 accumulation (Figure 
5.5).  We next examined tissue samples from patients diagnosed with CP.  IHC 
for ATF3 revealed limited staining above background in non-pancreatitis samples 
(Figure 5.6A-C) while CP samples showed extensive nuclear ATF3 localization in 
acinar cells (Figure 5.6D-F). Taken together, these findings suggest ATF3 
promotes loss of MIST1 expression and acinar cell differentiation during 
pancreatitis. 
5.3.4 « ATF3 Represses Mist1 Expression During CIP» 
 
To determine if the Mist1 gene was a direct transcriptional target of ATF3 
repression, ChIP-qPCR was performed to assess ATF3 occupancy of the Mist1 
promoter during CIP.   Analysis of multiple regions upstream of the Mist1 
transcriptional start site (TSS; Figure 5.7A) revealed no ATF3 enrichment along 
the Mist1 promoter under saline control conditions (Figure 5.7B,C), including 
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regions as far as 5 kb upstream of the TSS. Within four hours of inducing 
pancreatitis, peak enrichment for ATF3 was observed in a region spanning -2593  
to -2424 relative to the Mist1 TSS (Figure 5.7B,C).  Interestingly, XBP1s also 
appeared to associate with this same region of the Mist1 gene only after CIP 
(Appendix Figure A2).  Examination of the 5 kb genomic region upstream of the 
Mist1 promoter with PATCH (Pattern Search for Transcription Factor Binding 
Sites; www.biobase.com) identified three putative ATF/CRE consensus sites, two 
of which are on the reverse strand, at -2541 (TTACGTCA) and -2428 
(TTGCGTCA) relative to the Mist1 TSS (Figure 5.8). Both sites were contained 
within the region identified as enriched for ATF3 by ChIP analysis.  Sequence 
alignment with ClustalW2 (www.ebi.ac.uk/Tools/msa/clustalw2/) determined that 
the ATF/CRE sites are conserved between mus musculus, canis lupus familiaris 
and homo sapiens sequences.  The ATF/CRE site located at -2541 exhibited 
50% sequence homology between the three species, whereas the ATF/CRE site 
at -2428 exhibited 62.5% sequence homology.  
Next, the requirement of ATF3 for repression of Mist1 expression during CIP was 
examined in Atf3-/- mice. Atf3-/- mice express MIST1 within the pancreas to 
comparable levels relative to genetically-matched WT tissue. Four hours into the 
induction of pancreatitis, IF revealed maintenance of MIST1 nuclear 














Figure 5.5.  ATF3 is Localized to Areas Where MIST1 is not Expressed 
During Recovery from CP.  Serial sections of pancreatic tissue from mice with 
chronic pancreatitis were examined for MIST1 (A,B) and ATF3 (C,D) expression.    
By day 28, ATF3 expression was limited to focal pockets (C) that do not express 
MIST1 (A).  B and D are magnified regions of boxed areas in A and B.  






Figure 5.5. ATF3 is Localized tp Areas Where MIST1 is not 










Figure 5.6.  ATF3 is Expressed in the Pancreatic Tissue of Chronic 
Pancreatitis Patients.  Immunohistochemical analysis for ATF3 in pancreatic 
tissue from (A-C) patients with no pancreatic disease or (D-F) patients suffering 
from chronic pancreatitis.  Boxed areas are magnified to illustrate individual acini, 
where there is no nuclear expression of ATF3 observed (dotted line outlines an 
acinus).  Note that pancreatic tissue from chronic pancreatitis patients reveals 






















Figure 5.7. ATF3 Occupies the Mist1 Promoter During CIP. (A) Schematic 
representation of the Mist1 gene denoting the transcription start site (TSS) and 
consensus ATF/CRE binding sites (filled ovals). Scale bar = 1 kB.  (C) ChIP-PCR 
or (D) ChIP-qPCR analysis of ATF3 occupancy for areas designated in A along 
the Mist1 promoter 4 hours after initial saline or cerulein (CIP) injections. White 
bars represent ATF3 ChIP and black bars represent ChIP with a normal rabbit 
IgG as a negative control. N = 3; * p < 0.001). For qRT-PCR, Mist1 mRNA 






Figure 5.7. ATF3 Occupies the Mist1 Promoter During CIP. 
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Figure 5.8.  Sequence Alignment of the Mist1 Promoter Region.  Sequence 
analysis of the region spanned by primer set B (-2533 to -2317). Alignment was 
carried out between mus musculus, canus lupus familiaris and homo sapiens 















Figure 5.9.  Mist1 Expression is Maintained in Atf3-/- Mice During CIP. IF for 
MIST1 in WT (A,B) and Atf3-/- (C,D) pancreatic tissue following four hours of 
cerulein or saline treatment.  (E) Magnification bar = 26 µm.  Sal = saline, CIP = 
cerulein induced pancreatitis. qRT-PCR for MIST1 in WT and Atf3-/- pancreatic 
tissue following four hours of cerulein or saline treatment. Mist1 mRNA 






















D).  QRT-PCR analysis showed that Mist1 mRNA was not reduced in CIP-treated 
Atf3-/- pancreatic tissue indicating that ATF3 is required for repression. 
 
To determine the mechanism by which ATF3 represses Mist1 expression and 
whether the role of ATF3 was only to promote the loss of the acinar cell 
phenotype during pancreatitis.  To do this, another target of ATF3 binding was 
identified. Growth arrested and DNA damage inducible (Gadd) 34 gene, which 
contains an ATF/CRE binding site in its promoter region (Ma and Hendershot, 
2003), is upregulated during CIP (Kowalik et al., 2007) and activated by ATF3 
over-expression independent of PERK activation (Jiang et al., 2004).  ChIP-PCR 
and qPCR analysis spanning 5 kb upstream of the Gadd34 TSS (Figure 5.11B,C) 
revealed no significant occupancy of ATF3 until initiation of CIP (Figure 5.11B,C). 
Significant enrichment of ATF3 was observed within 250 bp of the Gadd34 TSS 
where the ATF/CRE consensus sequence is located (Figure 5.11B,C).  
Interestingly, Gadd34 expression was still increased in CIP-treated Atf3-/- 
pancreata indicating ATF3 is not required for Gadd34 expression (Appendix 










Figure 5.10. Differentiation Characteristics are Maintained in At3-/- 
Pancreatic Tissue During CIP. IF analysis for expression of PKCζ (A-D), β-
catenin (E –H), zona occludens 1 (ZO-1; I-L) or connexin 32 (Cx32; M-P) in wild 
type (WT) and Atf3-/- animals treated with either saline (SAL) or cerulein (CIP) to 
induce pancreatitis for 4 hours. Magnification bar = 15 µM. Individual acini have 
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Figure 5.11.  ATF3 Binds the Gadd34 Promoter During CIP.  (A) Schematic of 
the mouse Gadd34 gene with exons (boxes) and coding sequence (black box) 
indicated. A previously identified ATF binding site is located in primer set E (filled 
oval) transcriptional start site (TSS). Scale bar = 1kB. (B) ChIP-PCR or (C) ChIP-
qPCR analysis of ATF3 occupancy at each region of the Gadd34 promoter 
during control (saline) conditions or 4 hours into CIP. White bars represent ATF3 
ChIP and black bars represent ChIP with a normal rabbit IgG negative control. N 











































5.3.5 « ATF3 Recruits HDAC5 during Repression of Mist1» 
ATF3 can bind and recruit HDAC1 to gene promoters in the kidney (Li et al., 
2010).  Previous microarray analysis of pancreatic gene expression following 
saline or cerulein treatment suggested that HDACs 1, 3, 5, 6 and 7A were all 
expressed in pancreatic tissue (Kowalik et al., 2007), but only HDAC5 showed 
any increase in expression during CIP.  ChIP-qPCR analysis revealed HDAC5 
recruitment to the same region of the Mist1 promoter enriched for ATF3 during 
CIP (Figure 5.12A,B). HDAC5 was not recruited to the ATF3-bound region of the 
Gadd34 promoter during CIP (Figure 5.12C), illustrating a dual mechanism 
where ATF3 recruits HDAC5 during gene repression but not during gene 
activation. This recruitment was specific to HDAC5, as HDAC1 was not recruited 
to the Mist1 promoter during CIP (Figure 5.12B).  ChIP-PCR and ChIP-qPCR 
revealed no HDAC5 recruitment to the Mist1 promoter following cerulein 
treatment in Atf3-/- pancreata (Figure 5,12 A,B) indicating that ATF3 is required 
for HDAC5 recruitment to the Mist1 promoter.   
 
5.4 « Discussion» 
Defining the early molecular events that occur during pancreatic injury is 
important for understanding the mechanisms that dictate pancreatitis severity.  
This is particularly important as individuals hospitalized for pancreatitis have a 
25% mortality rate and patients with CP are 53-fold more likely to develop 









Figure 5.12.  ATF3 Recruits HDAC5 During Transcriptional Repression.  
(A) qPCR analysis for HDAC occupancy at regions A, B and D of the Mist1 
promoter revealed significant occupancy of HDAC5 at region B of the Mist1 
promoter in pancreatic tissue during CIP (n = 3 (* p < 0.01). (B) ChIP-PCR 
analysis revealed HDAC occupancy at region B of the Mist1 promoter only after 
CIP, and requires expression of ATF3 (Atf3-/- CIP; n = 3).  HDAC1 is not recruited 
to region B of the Mist1 promoter under any conditions. (C) ChIP-qPCR analysis 
revealed no occupancy of HDAC5 at region A of the Gadd34 promoter (n = 3).  











laboratories have shown that the UPR is activated within hours of initiating injury, 
as well as by a number of conditions that predispose an individual for 
pancreatitis, most notably chronic ethanol consumption or a diet high in fat 
(Alahari et al., 2011; Kowalik et al., 2007; Kubisch et al., 2006; Lugea et al., 
2011).  However, the effects of the UPR on acinar cell biology and tissue 
damage in the context of injury have not been elucidated.   In this study, we have 
identified a novel relationship between the UPR and Mist1 that affects acinar cell 
differentiation. ATF3, a mediator of the UPR, recruits HDAC5 to the Mist1 
promoter leading to repression of transcription.  MIST1 is required for complete 
acinar cell maturation and its expression is dramatically decreased in acinar 
tissue of patients with CP.  Since ATF3 expression is enhanced in both animal 
models and patient samples for CP, the identification of ATF3 repression of Mist1 
provides important mechanistic insight into the initiating molecular events of 
exocrine pancreas injury, and into mechanisms by which MIST1 expression can 
be compromised.  
While other studies have identified a role for ATF3 in promoting cell 
differentiation (Filen et al., 2010; James et al., 2006; Xu et al., 2011), this is the 
first study to link ATF3 to repression of cell differentiation status.  Surprisingly, 
ATF3 targets the Mist1 gene, which has been identified as a target of XBP1s.  
XBP1s binds to the Mist1 promoter approximately 60 bp upstream of the TSS 
and activates expression in both myoblast (Acosta-Alvear et al., 2007) and 
gastric zymogenic cells (Huh et al., 2010). The XBP1s mediated activation of 
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Mist1 promotes differentiation in zymogenic cells, but promotes loss of the 
myogenic phenotype upon activation of the UPR.  We have shown that, in the 
pancreas, XBP1s did not bind the Mist1 promoter under physiologic conditions 
but was recruited upon CIP treatment. In fact, both ATF3 and XBP1s bind a 
region approximately 2.5 kb upstream of the Mist1 TSS. Whether XBP1 is part of 
the repressive complex bound to this region of the Mist1 promoter is unclear, but 
it suggests an interesting possibility in which XBP1s binding is altered along the 
same promoter to change its role from activating to repressive. It is likely that 
differences in the transcriptional network between myoblasts and acinar cells 
account for the unique outcomes.  What is clear is that ATF3 is required for 
HDAC5 recruitment to the -2500 bp ATF/CREB site within the Mist1 promoter 
and that repression overrides any inductive effects XBP1s would have.   
The specificity of HDAC5 for ATF3-induced repression was supported by our 
findings that ATF3 was recruited to genes with increased expression during CIP, 
such as Gadd34.  In this situation, HDAC5 was not recruited and gene 
transcription proceeded, indicating that HDAC recruitment is a mechanism of 
ATF3-regulated gene repression. The role of ATF3 at the Gadd34 promoter is 
less clear.  ATF3 splice variants lacking a leucine zipper domain are thought to 
act as transcriptional activators by sequestering repressive factors from gene 
promoters (Chen et al., 1994).  However, we observed that ATF3 is bound to the 
Gadd34 promoter.  It is possible that ATF3 does not directly interact with the 
Gadd34 promoter since ATF/CREB family members can dimerize (Hai and 
Hartman, 2001), and perhaps ATF3 was dimerized with ATF4, a known 
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transcriptional activator of Gadd34 (Ma and Hendershot, 2003). This notion is 
supported by the fact that Gadd34 upregulation during CIP is not altered in Atf3-/- 
pancreatic tissue (Appendix Figure A3), indicating that ATF3 is not absolutely 
required for its expression. 
Our work shows that ATF3 was required for the observed loss of 
differentiated cell characteristics including cell polarity and cellular junctions, but 
does not resolve whether ATF3 plays a transcriptional role at each promoter.  
What is clear is that ATF3 binds to the Mist1 promoter to induce its repression 
during CIP.  This singular transcriptional event may be a trigger for subsequent 
loss of polarity and junctional markers since MIST1 is a transcriptional regulator 
required for proper acinar cell maturation. Thus, the loss of Mist1 may be 
resulting in the loss of transcriptional activation at these polarity and junctional 
promoters. Further evidence to support this is illustrated in Mist1-/- mice where 
Cx32 expressions is absent.  The finding that Mist1 expression was maintained 
during CIP in Atf3-/- tissue, along with expression of junctional and polarity genes, 
supports a model including MIST1.  
What is still unclear is whether the loss of acinar cell differentiation 
characteristics during pancreatitis is a protective mechanism, or if it is a measure 
of cell damage.  The theory that loss of acinar cell differentiation is protective 
may be counterintuitive at first, but it is possible that the cell is more capable of 
dealing with insult in a less differentiated state.   In this work, the experimental 
CIP time point is too early to assess longer-term pancreatitis severity measures 
like serum amylase and tissue necrosis, which would clarify whether the 
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maintenance of acinar cell differentiation is protective or damaging.  However, 
the persistence of ATF3 expression and concomitant absence of MIST1 
expression (Johnson et al., 2012) in pancreatic tissue from patients with CP 
indicates that ATF3 accumulation an loss of MIST1 are not early response 
protective mechanisms.  Furthermore, the increased expression of ATF3 in CP 
coinciding with decreased expression of MIST1, suggests that ATF3-mediated 
repression of Mist1 expression may be a contributing factor for pancreatitis in 
humans.   
In conclusion, this study uncovers a molecular role for ATF3 and the UPR 
during pancreatitis, and gives insight into how acinar cell differentiation and Mist1 
expression are regulated during injury.  The study also provides a mechanism by 
which environmental factors that enhance the UPR can promote pancreatitis and 




Chapter 6  
6 « Summary and Discussion » 
The purpose of this study was to determine whether the PERK pathway 
contributes to exocrine pancreas pathology at both a transcriptional and 
molecular level.  To determine the molecular role of the PERK pathway, the 
effect of STC2 overexpression on exocrine pancreas injury was assessed 
following repeated doses of cerulein to initiate pancreatitis.  Assessment of 
pancreatitis severity parameters revealed a muted elevation in serum amylase, 
decreased necrosis, and increased maintenance of cellular junctions, indicative 
of a role for STC2 in reducing the severity of exocrine pancreas injury.   
To uncover a transcriptional role for the PERK pathway, a protocol for chromatin 
immunoprecipitation from whole pancreatic tissue was designed.  This allowed 
for analysis of the contribution of the transcription factors ATF3 in pancreatitis.  
ATF3 occupied the Mist1 promoter during pancreatitis, and studies with Atf3-/- 
mice revealed that ATF3 was required for the downregulation of Mist1 expression 
during CIP.  Furthermore, this regulation was conferred through recruitment of 
HDAC5 by ATF3.  Thus, this work illustrates a dual role for the PERK pathway in 




6.1 « STC2 » 
STC2 has been previously associated with the PERK pathway in vitro.  This is 
the first study to link STC2 to the PERK pathway in vivo through overexpression 
and subsequent alteration in PERK pathway activation.  Furthermore, this study 
illustrates that STC2 expression was upregulated during pancreatitis, illustrating 
that it is part of a pathological response mechanism.  Upregulation of STC2 
during pancreatitis is not observed in a mouse model of increased pancreatitis 
severity (Mist1-/-), indicative of a protective role.  Additionally, STC2Tg mice 
exhibit decreased severity of pancreatitis based on numerous parameters, 
including decreased cellular necrosis, increased maintenance of cell junctions 
and a muted increased in serum amylase.  
Furthermore, STC2Tg mice exhibit altered development and function of the 
endocrine pancreas.  While islet composition and glucose tolerance are altered in 
these mice, further studies are required to solidify an endocrine defect.  
Assessment of insulin secretion during GSIS would indicate whether STC2Tg 
exocrine pancreata are deficient in sensing glucose or producing insulin.  To 
deterime whether these mice are insulin resistant, insulin stimulated insulin 
release could be performed, where decreased secretion of insulin after 
stimulation would indicated insulin resistance. 
In terms of the exocrine pancreas, PERK pathway activation in STC2Tg 
pancreata during pancreatitis was aberrant, where PERK and eIF2α both exhibit 
increased phosphorylation and ATF4 expression is increased. However, it is 
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important to consider that eIF2α  can be phosphorylated via mechanisms other 
than PERK, indicating that the observed alteration in PERK phosphorylation may 
be secondary to a peIF2α driven mechanism in these mice.   
The dysregulation of these molecules indicates that pancreatic tissue 
overexpressing STC2 was more sensitive to pancreatic insult, and that this tissue 
may be primed to respond to lower levels of injury.  This priming effect results in 
more efficient induction of the UPR during injury, resulting in earlier presence of 
protective effects and decreased pancreatitis severity, as observed in STC2Tg 
tissue.   Interestingly, ATF3 was not involved in this priming phenomenon, where 
it was only expressed in STC2Tg tissue after induction of pancreatitis.  However, 
its expression was more robust than that seen in WT tissue under the same 
conditions.  This observation might indicate that other factors are required for 
expression of ATF3.   Additionally, ATF3 may be required for the acinar cell 
response that is present in only pancreatitis and not after saline treatment, 
including loss of acinar cell differentiation.   
6.2 « ATF3 » 
Unlike other members of the PERK pathway, ATF3 was not expressed at 
detectable levels in pancreatic exocrine tissue under normal physiologic 
conditions.  This indicates that, while other PERK pathway members have a role 
in normal physiology of the cell, the role of ATF3 was strictly as a stress 
response gene. Since ATF3 is a transcription factor, further elucidation of its role 
during pancreatitis required identification of its transcriptional targets. ATF3 had 
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been previously implicated in cell differentiation (Filen et al., 2010; James et al., 
2006; Xu et al., 2011), suggesting that MIST1, a regulator of acinar cell 
differentiation, may be a potential target. Mist1 expression was decreased during 
pancreatitis, in addition to loss of cell polarity and junctional complexes, 
indicative of a loss of acinar cell differentiation. ATF3 binds to the Mist1 promoter 
only after induction of pancreatitis, to a region that contains two ATF/CRE 
consensus sequences.  When bound to the Mist1 promoter during pancreatitis, 
ATF3 recruits HDAC5, which is known to act as a repressor of transcription 
(Lemercier et al., 2000).  ATF3 was required for HDAC5 recruitment under these 
conditions since assessment of the Mist1 promoter in Atf3-/- mice revealed no 
HDAC5 recruitment.    Additionally, Mist1 expression was not decreased in Atf3-/- 
during pancreatitis, indicating that ATF3 and HDAC5 are critical to this process.  
These observations are novel, outline a mechanism of ATF3-mediated gene 
repression, and identify important transcriptional regulators of Mist1.   
While ATF3 and HDAC5 are important for transcriptional downregulation of 
Mist1, the observation that MIST1 protein expression decreases as early as one 
hour after the induction of pancreatitis inidicates that another mechanism is at 
play since one hour is likely too soon to be a wholly ATF3-based transcriptional 
mechanism.  Thus, the early downregulation of MIST1 protein might occur via 
enhanced protein degradation through either decreased protein stability or 
increased activation of degradation mechansims.   
The specificity of the ATF3/HDAC5 repressive complex is illustrated by analysis 
of the Gadd34 promoter.  GADD34 is a PERK pathway member that is 
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upregulated during pancreatitis and serves as a negative feedback mechanism to 
dephosphorylate peIF2α (Ma and Hendershot, 2003).  ATF4 regulates Gadd34 
expression, and there is an identified ATF/CRE consensus site in the Gadd34 
promoter (Ma and Hendershot, 2003).  This study shows a novel occupancy of 
the Gadd34 promoter by ATF3 in the absence of HDAC5, occurring during 
pancreatitis, when Gadd34 expression is increased.  Thus, ATF3 binds to 
promoters of both active and repressed genes, with HDAC5 recruited only in the 
repressive situation.  This duality is in keeping with a previously postulated 
mechanism where full length ATF3 acts as a repressor and ATF3 splice variants 
lacking leucine zipper motifs act as transcriptional activators by sequestering 
inhibitory factors from gene promoters (Figure 1.4B).  The work presented here 
extends this hypothesis, and shows that ATF3 acts as a repressor and activator 
by binding DNA in both circumstances, and the differentiating factor between 
activation and repression is other members of the transcriptional complex, 
including HDAC5.  However, Gadd34 expression during pancreatitis is not reliant 
on expression of ATF3, since Atf3-/- pancreata exhibit similar levels of Gadd34 
upregulation during pancreatitis (Appendix Figure A3). 
6.3 « A dual role for PERK Pathway Activation » 
Analysis of the onset of mRNA expression reveals robust upregulation of Atf3 
one hour after the induction of pancreatitis, with Stc2 expression following by 4 
hours (Figure 2.2).  These observations suggest a model where ATF3 promotes 
Stc2 expression, and the two work in a linear pathway following PERK/ATF4 
  
175 
activation. If ATF3 and STC2 are involved in the same processes following CIP, 
then Atf3-/- and STC2Tg lines should exhibit opposite responses to induction of 
pancreatitis. However, this study revealed similar protective response in both 
mouse models following induction of pancreatitis.  This reveals a non-linear 
relationship between ATF3 and STC2, and indicates that activation of the PERK 
pathway may have two opposing outcomes with STC2 serving as a protective 
molecule and ATF3 promoting damage during pancreatitis.   
It is counterintuitive for a singular pathway to promote opposing cellular 
responses, especially via two molecules regulated by the same transcription 
factor, ATF4, indicating that the timing of each event might be of importance.  
Atf3 is rapidly upregulated on hour after the induction of pancreatitis, and 
contributes to loss of acinar cell differentiation and polarity.  Thus, the loss of 
acinar cell differentiation and polarity is an immediate response.  Stc2 expression 
is first seen at 4 hours after the induction of pancreatitis, indicating that the 
cellular events it mediates follow those instigated by ATF3.  Since STC2 serves 
to downregulate phosphorylation of PERK and eIF2α and potentially dampen the 
activity of the PERK pathway, its role could be to counteract the outcome of 
ATF3 activity and for example, initiate restoration of cell polarity (Figure 6.1).  
One caveat to consider is that the observations are based on assessment of a 
model of STC2 overexpression, which may not be reflective of physiological or 
pathological STC2 levels in the pancreas.  Endogenous STC2 expression in the 
pancreas after induction of pancreatitis is virtually undetectable (data not shown) 
and while protein content visualized by IF cannot be compared between STC2 
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and ATF3, and is also not indicative of the individual protein potency, this 
observation could illustrate that the amount of STC2 present at the assessed 
time point is not required to completely counteract the activation of PERK 
pathway activation, but to modulate its activity in a rheostat-like fashion.    
Another point to consider is whether the loss of polarity and cell differentiation is 
actually detrimental or advantageous.  It is possible that acinar cells revert to a 
less differentiated phenotype that may be better equipped to deal with tissue 










Figure 6.1. Proposed Mechanism of PERK Activity.  Activation of the PERK 
pathway leads to ATF4-mediated expression of STC2 and ATF3.  This study 
illustrates a role for ATF3 in repressing Mist1 expression, that is a key acinar cell 
differentiation molecule (red line 1), and that XBP1 may contribute to this process 
(red dotted line, ?).  Additionally, STC2 acts a feedback mechanism to decreased 





























of serum amylase and exocrine tissue fibrosis are based on amylase and other 
digestive enzymes leaking between cells and into the tissue and vasculature.  
This process is facilitated by the loss of cellular junctions, namely tight junctions, 
which normally form a barrier to such events. Examination of CIP responses at 
four after initial injections allowed for assessment of early events in pancreatitis, 
including induction of transcriptional cascades that contribute to cellular response 
to stress.  However, assessment of tissue fibrosis and serum amylase at this 
early timepoint does not give a full representation of disease severity since peak 
serum amylase levels, apoptosis and necrosis occur several hours later after 
initiating pancreatitis. Therefore, ongoing studies include assessment of 
pancreatitis severity at later timepoints in Atf3-/- mice in order to determine the 
contribution of ATF3 to disease severity.   
6.4 « Cross-talk Between UPR Pathways » 
This work also uncovers a unique interaction between the PERK and IRE 
signaling pathways.  Both XBP1 and ATF3 are recruited to the Mist1 promoter 
during CIP.  Little is known about Mist1 transcriptional regulation, other than 
activation by XBP1 during cultured myoblast differentiation (Acosta-Alvear et al., 
2007) and during gastric zymogenic cell differentiation (Huh et al., 2010).  The 
potential presence of XBP1 at the Mist1 promoter during a time of repression 
would be a novel finding since previous work showed that XBP1 activates Mist1 
expression during cell differentiation.  However, the present work indicates that 
XBP1 may be enriched at a region further upstream from the Mist1 TSS (Acosta-
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Alvear et al., 2007).  While I have not been able to show a direct interaction  
between XBP1 and ATF3 due to limitations of the antibodies, such an interaction 
is possible since both are bZIP proteins that can heterodimerize (Hai et al., 1989; 
Ono et al., 1991). A contribution of XBP1 in this process is appealing for 
numerous reasons.  First, this would reveal a novel interaction between ATF3 
and XBP1, and would be indicative of cross-talk between two distinct UPR 
pathways.  Second, it would reveal a dual role for XBP1 in the regulation of Mist1 
that is context dependent, where it is activating during cell differentiation and 
repressive during cell injury. XBP1 is consistently expressed in the adult exocrine 
pancreas indicating it has a role outside of cell differentiation, and that the role of 
XBP1 in the pancreas is context dependent, just as it may be during pancreatic 
injury.   
6.5 « Future Directions » 
Since the this study presents only preliminary evidence that XBP1 participates in 
the ATF3 driven repressive complex, further analysis of XBP1 occupancy at the 
Mist1 promoter during CIP should be carried out.  Additionally, co-
immunoprecipitation studies should be carried out to determine if XBP1 and 
ATF3 do, in fact bind to each other, or are located within the same complex.  
Similarly, ChIP re-ChIP should be carried out to determine if they are both, in 
fact, occupying the same region of the Mist1 promoter at the same time.    
Further analysis by inducing CIP in mice lacking Xbp1 in the exocrine pancreas 
(Xbp1ΔEx2) may be carried out.   
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Clear evidence has been presented that ATF3 recruits HDAC5 to form a 
repressive complex at the Mist1 promoter.  To extend this analysis, CIP 
experiments can be carried out in mice lacking Hdac5 (Hdac5-/-) (Chang et al., 
2004) to observe whether these mice exhibit a response to pancreatitis similar to 
that seen in Atf3-/- mice.  Additionally, determining whether ATF3 occupies the 
Mist1 promoter in the absence of HDAC5 will strengthen the conclusion that 
ATF3 recruits HDAC5 in this process.     
To further elucidate whether ATF3 is protective or deleterious during pancreatitis, 
Atf3-/- mice should be examined over a longer time period of CIP exposure and 
assessed for severity parameters including serum amylase, edema and fibrosis.  
Additionally, the exocrine pancreas of mice overexpressing ATF3 (ATF3Tg) can 
be examined to observe whether cells exhibit similar characteristics seen during 
pancreatitis.  Additionally, generating ChIP material suitable for ChIP-Seq would 
confirm the ChIP results presented here, and uncover novel ATF3 transcriptional 
targets. 
6.6 « Conclusion » 
This work illustrates that the PERK pathway is responsive during pancreatitis.  In 
both a transcriptional (ATF3) and a molecular (STC2) fashion, and that activation 
of these molecules elicit opposing responses, illustrating a dual role for this 
pathway.  Furthermore, the expression of ATF3 in human pancreatitis samples 
reveals a potential clinical role for ATF3 in exocrine pancreas pathology. 
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Appendix Figure A1. Activation of the PERK Pathway in Response to 
Pancreatitis is Altered in Stc2Tg Mice. (A) Western blot analysis of PERK 
pathway members during pancreatitis (CIP) and treated with a saline control in 
wild type (WT) and Stc2Tg (Tg) tissue.  (B) Analysis of PERK phosphorylation in 







Appendix Figure A 1. Activation of the PERK Pathway in 
Response to Pancreatitis is Altered in STC2Tg Mice. 





























Appendix Figure A2.  XBP1 binds to region B of the Mist1 promoter during 
CIP. (A) PCR analysis revealed that XBP1 binds region B of the Mist1 promoter 
only during CIP.  (B) qPCR confirms XBP1 binding to region B during CIP.  N = 2.  



















Appendix Figure A 3. ATF3 is Not Required for Gadd34 Expression During 
CIP. qRT-PCR revealed that the increase in Gadd34 expression seen in wild 
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